{"study_id": 14502, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine the role of the glutamate-glutamine cycle in seizure susceptibility in Alzheimer's disease and test the effect of ceftriaxone, a GLT-1 enhancer, on seizure susceptibility in a mouse model of AD.", "results_summary": "The study found reduced levels of GLT-1 and glutamine synthetase in Tg2576 mice, and ceftriaxone treatment did not significantly alter seizure susceptibility compared to saline-treated controls.", "population_specificity": "Tg2576 mouse model of Alzheimer's disease and wild-type littermates.", "effective_dosage": "200 mg/kg ceftriaxone.", "study_duration": "Seven days before kindling.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:56:51.030409+00:00"}
{"study_id": 14507, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of glutamate metabolism in Invasive Lobular Carcinoma (ILC) and its potential as a therapeutic target, particularly in Black women.", "results_summary": "The study found that glutamate-related proteins (SLC3A2, SLC7A11, GPX4, GLUD1/2) were associated with increased tumor size and poorer outcomes in ILC, with GLUD1/2 showing strong links to tumor progression in Black women. Inhibition of GLUD1 reduced ER protein levels and oxidative phosphorylation in therapy-resistant ILC cells.", "population_specificity": "72 ER+ ILC and 50 ER+ IDC/NST patients, with a focus on racial diversity, particularly Black women.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:56:52.090687+00:00"}
{"study_id": 189281, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review natural products that modulate the KEAP1/NRF2 pathway, including glutamate-related mechanisms, to identify potential antioxidant agents.", "results_summary": "The study highlights natural products targeting the KEAP1/NRF2 pathway, including glutamate-cysteine ligase (GCLC/GCLM), as effective in enhancing antioxidant responses, with potential therapeutic applications.", "population_specificity": "Not specified (review of in silico and experimental studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:56:58.080577+00:00"}
{"study_id": 189279, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers examined the role of glutamate in depleting glutathione (GSH) and contributing to GPx4 inactivation during stroke-related neuronal ferroptosis.", "results_summary": "Excess glutamate depletes GSH, overwhelming GPx4 and promoting ferroptosis in stroke; therapeutic strategies targeting GPx4 activity may counteract this effect.", "population_specificity": "Neuronal cells in ischemic and hemorrhagic stroke models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:56:58.357840+00:00"}
{"study_id": 189282, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to investigate the prognostic impact of glutamine metabolism in severely but not critically ill medical patients.", "results_summary": "The abstract does not provide specific results regarding glutamate's effects, only mentioning that glutamine and glutamate serve as main energy substrates for immune cells and their plasma levels drop during severe illness.", "population_specificity": "Severely but not critically ill medical patients.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:56:58.854149+00:00"}
{"study_id": 189278, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to develop an automated data quality control (DQC) pipeline (VECTORS) to improve the reliability of MR spectroscopy, particularly in detecting artifacts related to glutamine + glutamate peak shapes.", "results_summary": "The study found that standard quantitative metrics for DQC were not sufficient, as they did not align with manual ratings. VECTORS successfully identified additional poor-quality spectra missed by manual ratings and standard metrics, improving artifact detection.", "population_specificity": "110 young adults", "effective_dosage": "Not available", "study_duration": "Not applicable (study focused on methodology, not intervention)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:56:59.266078+00:00"}
{"study_id": 14509, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the efficacy and safety of the arginine-glutamate ion pair (RE:pair) in improving skin barrier function and relieving itching in patients with burn scars.", "results_summary": "The study found significant alleviation of itching, an 11% improvement in transepidermal water loss (TEWL), and a 41% improvement in skin corneum hydration (SCH) after 4 weeks of treatment with RE:pair.", "population_specificity": "10 patients with burn scars.", "effective_dosage": "Twice daily application (specific amount not provided).", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:56:59.905346+00:00"}
{"study_id": 189283, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to assess the impact of supplemental folic acid on the expression of folate transporters/receptors and glutamate carboxypeptidase II (GCPII) in the terminal ileum and colon.", "results_summary": "The study found that folate transporters are present throughout the terminal ileum and colon, with little evidence that low-dose folic acid supplementation affects colonic absorption, except for higher mRNA expression of FR-alpha and GCPII in the ascending colon with supplementation.", "population_specificity": "Adults consuming a low folic acid-containing diet.", "effective_dosage": "400 \u03bcg folic acid supplement.", "study_duration": "16 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:00.107700+00:00"}
{"study_id": 189284, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 65, "study_goal": "The researchers aimed to determine whether oral glutamine supplementation could restore brain metabolite levels (glutamate and glutamine) in MELAS syndrome patients.", "results_summary": "The study found no significant changes in glutamate and glutamine (Glx/creatine) levels in the brain after glutamine supplementation, nor any differences between MELAS patients and controls. A positive correlation was observed between CSF lactate and brain lactate/creatine levels in the parieto-occipital cortex.", "population_specificity": "Nine patients with MELAS syndrome (35.8 \u00b1 3.2 years) and nine age- and sex-matched controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:01.362090+00:00"}
{"study_id": 189285, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of glutamate in citrin deficiency (CD) and the effectiveness of medium-chain triglyceride (MCT) supplements in addressing energy deficiencies caused by CD.", "results_summary": "The study found that citrin-deficient hepatocytes have impaired glycolysis and lipogenesis due to glutamate-related dysfunction, leading to energy deficiencies. MCT supplementation was effective in providing energy and improving lipogenesis, but patients still exhibited growth impairment and irreversible organ damage.", "population_specificity": "Patients with citrin deficiency (CD), including those with neonatal intrahepatic cholestasis (NICCD), failure to thrive and dyslipidemia (FTTDCD), and adult-onset type 2 citrullinemia (CTLN2).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:01.914273+00:00"}
{"study_id": 189286, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to characterize the hypo-lipidemic effects of Brumex\u2122, derived from Citrus bergamia, focusing on its impact on lipid metabolism and liver enzymes.", "results_summary": "Brumex\u2122 significantly reduced cholesterol, triglycerides, and lipid synthesis-related gene expression in HepG2 cells and improved plasma lipid profiles and liver enzyme levels in hyper-cholesterolemic subjects.", "population_specificity": "50 healthy, moderately hyper-cholesterolemic subjects", "effective_dosage": "400 mg daily", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:06.933069+00:00"}
{"study_id": 189288, "supplement_id": 1158, "safety_score": "75", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to determine whether high-dose oral glutamine supplementation could reduce elevated CSF glutamate levels and increase CSF glutamine levels in patients with MELAS syndrome.", "results_summary": "The study found that glutamine supplementation significantly reduced CSF glutamate levels and increased CSF glutamine levels in MELAS patients, with mild side effects reported in some participants.", "population_specificity": "Nine adult patients with MELAS syndrome (66.7% females, mean age 35.8 \u00b1 3.2 years).", "effective_dosage": "High-dose oral glutamine (specific amount not stated in abstract).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:07.364604+00:00"}
{"study_id": 189287, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the relationship between zinc and glutathione (GSH) in oxidative stress and neuronal cell death, and how modulating zinc could mitigate brain injury-induced neuronal damage.", "results_summary": "The study found that GSH has neuroprotective effects in brain injuries like cerebral ischemia, hypoglycemia, and traumatic brain injury by counteracting oxidative stress. However, excessive zinc influx inhibits GSH's antioxidant function, exacerbating neuronal damage and cognitive impairment.", "population_specificity": "Brain injury models (cerebral ischemia, hypoglycemia, traumatic brain injury)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:07.848008+00:00"}
{"study_id": 189290, "supplement_id": 1158, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to investigate the effects of monosodium glutamate (MSG) supplementation on taste receptor expression (T1R3) and dietary intake in healthy females.", "results_summary": "MSG supplementation at <10 g/day significantly increased T1R3 expression and taste sensitivity, improved protein, fat, and carbohydrate balance, and reduced salt and sugar intake. No effects were observed at >10 g/day.", "population_specificity": "Fifteen young healthy female volunteers.", "effective_dosage": "2.7 g/day or 0.27 g/day.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:08.400829+00:00"}
{"study_id": 189289, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the role of glutamine in immune function and brain metabolism, particularly its involvement in the glutamate/GABA cycle.", "results_summary": "The study highlights glutamine's critical roles in immune cell function, TCA cycle, and brain metabolism, but notes inconsistent results from supplementation studies. It also discusses emerging insights into glutamine's metabolic pathways.", "population_specificity": "Not specified (general review, potentially applicable to immune cells and brain metabolism in catabolic states like critical care or intense exercise).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:09.077491+00:00"}
{"study_id": 189291, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether dietary monosodium glutamate (MSG) supplementation could mitigate chemotherapy-induced dysgeusia and T1R3 taste receptor downregulation in head and neck cancer patients.", "results_summary": "MSG supplementation (2.7 g/day) significantly attenuated the reduction in T1R3 expression, taste sensitivity, and daily energy intake caused by chemotherapy, suggesting it may help counteract dysgeusia and improve nutritional intake.", "population_specificity": "Patients with advanced head and neck cancer undergoing chemoradiotherapy.", "effective_dosage": "2.7 g/day", "study_duration": "Administered during the second round of chemotherapy (duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:09.088537+00:00"}
{"study_id": 189293, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore how omega-3 supplementation influences glutamate pathways in schizophrenia, particularly in ultra-high risk (UHR) and first-episode psychosis (FEP) patients.", "results_summary": "Omega-3 supplementation was found to modulate glutamate pathways, similar to antipsychotics, and showed potential neuroprotective properties with minimal side effects. It also improved myelination and reduced inflammation and oxidative stress.", "population_specificity": "Ultra-high risk (UHR) and first-episode psychosis (FEP) patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:09.909385+00:00"}
{"study_id": 189292, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the neuroprotective effects of glutathione (GSH) and related molecules, particularly targeting the xCT-GSH synthetic system and Nrf2-ARE pathway in astrocytes, in Parkinson's disease (PD) pathology.", "results_summary": "The study found that dysfunction of antioxidative molecules like GSH is involved in PD pathogenesis, and agents targeting GSH synthesis in astrocytes protect dopaminergic neurons in PD models. The xCT-GSH system and Nrf2-ARE pathway in astrocytes were highlighted as potential therapeutic targets.", "population_specificity": "Parkinson's disease models (animal or cellular, not specified in abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:10.729743+00:00"}
{"study_id": 189296, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the neuroprotective potential of natural molecules, including kynurenic acid, in relation to glutamate excitotoxicity in neurodegenerative diseases.", "results_summary": "The abstract highlights kynurenic acid as a promising neuroprotective agent due to its role in mitigating glutamate excitotoxicity, alongside antioxidant, anti-inflammatory, and antiapoptotic effects. These properties make it a candidate for managing neurodegenerative diseases.", "population_specificity": "Not specified (general discussion of neurodegenerative diseases)", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:15.180264+00:00"}
{"study_id": 189297, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify biomarkers, including glutamate, that predict 90-day mortality and rehospitalization in malnourished hospitalized older patients.", "results_summary": "Glutamate, along with hydroxyproline and tau-methylhistidine, was significantly associated with 90-day mortality and readmission, demonstrating moderate predictive ability (C-statistic 0.68).", "population_specificity": "Malnourished hospitalized patients aged >65 years.", "effective_dosage": "Not available", "study_duration": "Not specified for glutamate measurement (outcomes tracked over 90 days).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:15.736961+00:00"}
{"study_id": 189299, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether a caloric restriction mimetic supplement could positively alter brain neurochemistry, including glutamate levels, in healthy middle-aged adults.", "results_summary": "The supplement group showed an increase in the Glu/Gln ratio, indicating enhanced excitatory neurotransmission and bioenergetics, though specific glutamate effects were not detailed beyond this marker.", "population_specificity": "Healthy middle-aged men and women (N=63, age 40-60 years).", "effective_dosage": "Not specified", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:16.549983+00:00"}
{"study_id": 189300, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to determine whether anserine, the active ingredient in chicken essence, affects exercise-induced oxidative stress, cell integrity, and haematology biomarkers.", "results_summary": "The abstract does not provide specific results regarding Glutamate's effects.", "population_specificity": "Ten healthy men.", "effective_dosage": "Low dose (ANS-LD) 15 mg/kg.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:16.617531+00:00"}
{"study_id": 189298, "supplement_id": 1158, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to determine whether oral MgSO4 therapy improves lipid profile, serum oxidized LDL levels, and its receptor (LOX1) in patients with moderate coronary artery disease.", "results_summary": "The study found that MgSO4 supplementation significantly reduced HbA1c, serum LOX1, oxidized LDL, and improved 2hpp, LDL cholesterol, SGPT, and SGOT levels compared to placebo, indicating potential benefits for atherosclerosis risk factors.", "population_specificity": "64 patients with moderate coronary artery disease confirmed by angiography.", "effective_dosage": "300 mg MgSO4 daily.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:16.685128+00:00"}
{"study_id": 189303, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the pathophysiology, symptomatology, and current treatments of Parkinson's Disease, including the role of glutamate accumulation in excitotoxicity.", "results_summary": "The abstract highlights that glutamate accumulation due to MAO-B activity contributes to oxidative stress and excitotoxicity in Parkinson's Disease, but does not provide specific study results on glutamate's effects.", "population_specificity": "Elderly individuals, particularly those over 60 years of age, with Parkinson's Disease.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:17.658006+00:00"}
{"study_id": 189304, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review experimental studies on glutamine's efficacy and its effects on gut microbiota.", "results_summary": "The study summarized that glutamine could influence gut microbiota through various mechanisms, including reducing certain ratios, but specific outcomes were not detailed in the abstract.", "population_specificity": "Not specified (in vitro, in vivo, and clinical studies reviewed).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:18.043462+00:00"}
{"study_id": 189301, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the therapeutic potential of Vitamin D and NAC in modulating glutamatergic neurotransmission and neuroimmune pathways for treatment-resistant MDD.", "results_summary": "The study suggests that NAC modulates synaptic glutamate release via the cysteine-glutamate antiporter and exhibits neuroprotective effects, while Vitamin D deficiency is linked to MDD, with supplementation potentially improving depressive symptoms.", "population_specificity": "Individuals with refractory Major Depressive Disorder (MDD), including special populations like youngsters and elders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:18.189088+00:00"}
{"study_id": 189310, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the potential mechanisms of action involving glutamate homeostasis in the relationship between micronutrient deficiencies (zinc, magnesium, selenium) and depression.", "results_summary": "The study suggests that glutamate homeostasis is one of the potential mechanisms linking micronutrient deficiencies, particularly zinc, to depression, though evidence for magnesium and selenium remains inconclusive.", "population_specificity": "Not specified (general discussion of micronutrient deficiency and depression).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:24.312605+00:00"}
{"study_id": 189307, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of oral supplementation of glutamate, along with other amino acids and micronutrients, on glutathione (GSH) metabolism and systemic oxidative stress.", "results_summary": "The study found that supplementation with glutamate, as a component amino acid of GSH, enhances tissue GSH synthesis. Additionally, non-precursor amino acids and micronutrients influenced the redox status of GSH and related antioxidants, reducing oxidative stress and slowing tissue deterioration.", "population_specificity": "Not specified (general eukaryotic cells and systemic oxidative stress models implied).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:24.593039+00:00"}
{"study_id": 189308, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of amantadine ER in reducing levodopa-induced dyskinesia (LID) in Parkinson's disease patients.", "results_summary": "The study found that amantadine ER is effective in reducing LID and OFF time, with several clinical trials supporting its use as the only FDA-approved medication for this purpose. The authors highlight its potential to supplement levodopa therapy and improve patient outcomes.", "population_specificity": "Parkinson's disease patients experiencing levodopa-induced dyskinesia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:25.279387+00:00"}
{"study_id": 189311, "supplement_id": 1158, "safety_score": "80", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of N-acetyl cysteine (NAC) in modulating glutamate neurotransmission and its potential as a treatment for refractory obsessive-compulsive disorder (OCD).", "results_summary": "The study suggests NAC may improve OCD symptoms by modulating glutamate release and inflammatory pathways, with potential benefits enhanced by vitamin D supplementation due to its role in glutathione formation.", "population_specificity": "Patients with treatment-resistant obsessive-compulsive disorder (OCD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:25.691725+00:00"}
{"study_id": 189306, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effect of dietary protein, particularly glutamate, on de novo lipogenesis and its role in lipid accumulation in the liver.", "results_summary": "High-protein feeding rich in glutamate increased de novo lipogenesis-associated triglycerides in plasma and liver-derived particles. Glutamate, glutamine, and leucine promoted triglyceride synthesis and reduced glucose uptake in hepatocytes, likely via the insulin signaling cascade.", "population_specificity": "Healthy males (n = 9 per group)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:26.653739+00:00"}
{"study_id": 189309, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the neuroprotective effects of testosterone against glutamate-induced toxicity and oxidative stress in neuronal cultures.", "results_summary": "Testosterone demonstrated a protective effect on neurons in culture against glutamate-induced toxicity and oxidative stress, and it stimulated myelin formation and regeneration mediated through the neural androgen receptor. However, evidence of a therapeutic effect of testosterone in clinical settings remains scarce.", "population_specificity": "Neuronal cultures (in vitro) and experimental autoimmune encephalomyelitis model (animal studies); human trials mentioned but not detailed.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:28.186995+00:00"}
{"study_id": 189312, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of the glutamate/cystine antiporter SLC7A11 in cancer cell survival and its potential as a therapeutic target.", "results_summary": "The study found that SLC7A11, which is overexpressed in several cancers, has unexpected effects on cancer cell survival under specific stress conditions, contrasting its known pro-survival roles.", "population_specificity": "Cancer cells with specific genetic alterations.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:28.817839+00:00"}
{"study_id": 189314, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of glutamate inhibition via the ketogenic diet in managing drug-refractory epilepsy, particularly in children and adolescents.", "results_summary": "The ketogenic diet, by elevating ketone concentrations, inhibits glutamate's synaptic activity, potentially increasing seizure thresholds and enhancing the effects of antiepileptic drugs. Clinical trials confirm its effectiveness, though adverse effects like gastrointestinal distress and metabolic issues limit its broader use.", "population_specificity": "Children and adolescents with drug-refractory epilepsy.", "effective_dosage": "Not specified (high-fat, low-carbohydrate diet with vitamin supplementation).", "study_duration": "Not specified.", "interactions": "Potentiates the anticonvulsant activity of some antiepileptic drugs.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:31.046409+00:00"}
{"study_id": 189316, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the interaction between AQP4 and GLT-1 in astrocytes and its potential role in neuroprotection against Alzheimer's disease.", "results_summary": "The study suggests that AQP4 deficiency impairs learning and memory, possibly linked to GLT-1 expression, and highlights the significance of the AQP4/GLT-1 complex in neuroprotection against Alzheimer's disease.", "population_specificity": "Not specified (focus on astrocyte mechanisms in Alzheimer's disease).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:32.385860+00:00"}
{"study_id": 189317, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of glutamate in cerebral metabolism, particularly its involvement in lactate production and neuroprotection following traumatic brain injury (TBI).", "results_summary": "Glutamate-induced activation of glycolysis in astrocytes stimulates lactate production, which is transferred to neurons and serves as an alternative energy source and signaling molecule. Exogenous lactate supplementation showed neuroprotective effects in TBI models, improving neuroenergetics and reducing brain edema.", "population_specificity": "Patients with traumatic brain injury (TBI) and animal models of brain injury (e.g., TBI, stroke).", "effective_dosage": "Hypertonic lactate infusions (specific dosage not detailed).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:34.887342+00:00"}
{"study_id": 189318, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The study aimed to examine the efficacy of combined grape pomace and omija fruit ethanol extracts (GO) on metabolic disorders in overweight or obese subjects, with a focus on dyslipidemia, inflammation, and oxidative stress.", "results_summary": "The high-GO supplement significantly improved plasma lipid profiles, reduced inflammatory markers, and enhanced antioxidant capacity without altering body weight or body fat. No significant differences in hepatotoxicity markers (glutamate oxaloacetate transaminase and glutamate pyruvate transaminase) were observed between groups.", "population_specificity": "Overweight or obese subjects (BMI \u226523.0 kg/m\u00b2, aged 30-70 years).", "effective_dosage": "Low-GO (342.5 mg grape pomace extract + 57.5 mg omija fruit extract/day), high-GO (685 mg grape pomace extract + 115 mg omija fruit extract/day).", "study_duration": "10 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:36.074571+00:00"}
{"study_id": 189321, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the potential therapeutic effects of ketone bodies, particularly \u03b2-hydroxybutyrate, on cognitive function in Alzheimer's disease, focusing on their interaction with glutamate metabolism.", "results_summary": "The study found that ketone bodies, at relatively low doses, may improve cognitive function in Alzheimer's patients by supporting energy metabolism or inhibiting A\u03b2-induced glutamate release, potentially reducing hyperexcitability and inflammation. However, the doses used were too low to affect neuronally released glutamate.", "population_specificity": "Alzheimer's disease patients, particularly those at pre-clinical or early stages.", "effective_dosage": "Relatively low doses of \u03b2-hydroxybutyrate (specific amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:36.363609+00:00"}
{"study_id": 189322, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the neuroprotective effects of LBPs against glutamate excitotoxicity and other neurotoxic insults.", "results_summary": "LBPs were found to protect against neuronal injury and loss induced by glutamate excitotoxicity, improve neurogenesis in the hippocampus and subventricular zone, and enhance learning and memory abilities in mice.", "population_specificity": "Preclinical models (mice) and in vitro studies; some clinical studies in healthy subjects.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:36.715021+00:00"}
{"study_id": 189323, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine if micronutrient deficiencies correlated with glutamate hyperactivity in patients with AWS (alcohol withdrawal syndrome).", "results_summary": "The study found statistically significant differences in micronutrient concentrations (zinc, magnesium, folate/vitamin B12/homocysteine) between AWS patients and healthy controls, suggesting a link between glutamate hyperactivity and these deficiencies. Supplementation of these nutrients may improve AWS symptom evolution.", "population_specificity": "Patients with alcohol withdrawal syndrome (N = 60) compared to healthy controls (N = 34).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:37.465102+00:00"}
{"study_id": 189324, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to understand the physiological functions of glutamate-glutamine exchange in placental amino acid transport and fetal development, particularly in sows.", "results_summary": "Glutamate and glutamine are highly utilized by the fetus during late gestation, with glutamate being cleared from fetal plasma and converted to glutamine by the placenta. Glutamine supplementation may improve fetal growth and reduce preweaning mortality in piglets.", "population_specificity": "Mammals, particularly sows, and human fetal development.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:39.931016+00:00"}
{"study_id": 189325, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess whether anterior cingulate Glx levels could differentiate bipolar from unipolar depression.", "results_summary": "Unipolar depression was associated with lower Glx levels compared to healthy controls, while bipolar depression showed a trend toward higher Glx levels. The difference between unipolar and bipolar depression was significant, suggesting Glx measurement could help differentiate the two with moderate sensitivity (0.66) and high specificity (0.85).", "population_specificity": "Depressed patients (unipolar and bipolar) compared to healthy controls.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:40.558785+00:00"}
{"study_id": 189327, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the potential benefits of creatine supplementation during pregnancy, particularly its neuroprotective effects against glutamate excitotoxicity in the fetal brain.", "results_summary": "The study suggests that creatine may counteract glutamate excitotoxicity by interacting with the GABAA receptor, potentially protecting the fetal brain from hypoxia-related damage. It also highlights creatine's broader neuroprotective and metabolic benefits.", "population_specificity": "Pregnant women and their fetuses, with implications for preterm or growth-restricted fetuses.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:44.500826+00:00"}
{"study_id": 189328, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether exogenous lactate supplementation reduces cerebral glutamate levels and improves energy metabolism in traumatic brain injury (TBI) patients.", "results_summary": "Sodium lactate therapy was associated with a reduction in cerebral glutamate levels (-0.95 mmol/L, p = 0.06) and improved cerebral energy metabolism, including increased lactate, pyruvate, and glucose concentrations.", "population_specificity": "15 consecutive patients with severe traumatic brain injury (TBI).", "effective_dosage": "Hypertonic sodium lactate infusion aiming to increase systemic lactate to approximately 5 mmol/L.", "study_duration": "3-hour intravenous infusion.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:44.936242+00:00"}
{"study_id": 189330, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to examine how carbohydrate administration affects circulating glutamate concentrations and investigate glutamate's independent effect on glucose metabolism.", "results_summary": "Plasma glutamate levels significantly increased when supplemented, and glutamate blunted the glucose response to carbohydrate intake without consistently altering insulin secretion.", "population_specificity": "Nine participants (specific demographics not provided).", "effective_dosage": "150 mg/kg body weight of monosodium L-glutamate (MSG).", "study_duration": "Blood samples taken over 120 minutes post-intervention.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:45.621520+00:00"}
{"study_id": 189326, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether vitamin D and L-cysteine (LC) levels correlate with glutathione (GSH) levels in type 2 diabetic patients and whether these nutrients upregulate glutamate-cysteine ligase (GCLC), a key enzyme in GSH biosynthesis.", "results_summary": "The study found that vitamin D and LC supplementation significantly increased GCLC expression and GSH formation in monocytes, suggesting a positive relationship between these micronutrients and GSH levels. Plasma levels of vitamin D, LC, and GSH were lower in diabetic patients, and LC and vitamin D showed positive correlations with GSH levels.", "population_specificity": "Type 2 diabetic patients (n=79) and healthy controls (n=22).", "effective_dosage": "Vitamin D (0-25 nM), LC (0-500 \u03bcM).", "study_duration": "24 hours pretreatment, followed by 4 hours of exposure to control or high glucose.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:45.764729+00:00"}
{"study_id": 189329, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of vitamin D on glutamate excitotoxicity, a key pathological feature of ALS.", "results_summary": "Vitamin D treatment reduced neuronal lethality caused by glutamate insult in vitro and attenuated hypoxic brain damage in vivo, suggesting a protective role against glutamate excitotoxicity. High-dose vitamin D3 supplementation improved functional capacity in a mouse model of ALS, while restriction worsened it.", "population_specificity": "G93A mouse model of ALS and in vitro neuronal studies.", "effective_dosage": "High-dose vitamin D3 (specific amount not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:45.781323+00:00"}
{"study_id": 189319, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of glutamate in the pathogenesis of Huntington's disease (HD) and propose potential therapeutic strategies targeting oxidative stress, chronic inflammation, and glutamate dysregulation.", "results_summary": "The study suggests that excessive glutamate release contributes to HD progression alongside oxidative stress and chronic inflammation. Attenuating these biochemical abnormalities, including glutamate dysregulation, may delay symptom onset, potentially through activation of the Nrf2/ARE pathway and antioxidant supplementation.", "population_specificity": "Individuals with Huntington's disease (HD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:45.994103+00:00"}
{"study_id": 189331, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of diesel exhaust (DE) exposure on systemic miRNAs and oxidative stress markers, including the role of N-acetylcysteine supplementation, but did not specifically focus on Glutamate.", "results_summary": "The study found that DE exposure altered specific miRNAs (miR-144, miR-21) linked to oxidative stress, and N-acetylcysteine supplementation mitigated these changes. Glutamate-related mechanisms (GCLC) were indirectly implicated but not directly studied.", "population_specificity": "Thirteen participants with mild asthma.", "effective_dosage": "Not specified for Glutamate.", "study_duration": "Single acute exposure with measurements taken 6 hours post-exposure.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:49.343030+00:00"}
{"study_id": 189332, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the potential of glutamate or glutamine supplementation as an ergogenic aid to enhance exercise performance in COPD patients.", "results_summary": "The abstract notes conflicting results on glutamate or glutamine supplementation in COPD, with no clear long-term benefits demonstrated from acute intervention studies.", "population_specificity": "Patients with chronic obstructive pulmonary disease (COPD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:49.423751+00:00"}
{"study_id": 189335, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of various dietary interventions, including magnesium-pyridoxal-phosphate-glutamate, on improving lipid profiles.", "results_summary": "The study found that magnesium-pyridoxal-phosphate-glutamate supplementation could not be recommended for improving lipid profiles, indicating a lack of efficacy.", "population_specificity": "Participants in randomized controlled trials with a minimum of 50 individuals, focusing on dietary interventions for lipid profile improvement.", "effective_dosage": "Not specified", "study_duration": "At least 4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:54.144963+00:00"}
{"study_id": 189333, "supplement_id": 1158, "safety_score": "95", "efficacy_score": null, "quality_score": 90, "study_goal": "The researchers aimed to confirm the safety and tolerance of Bacteroides xylanisolvens DSM 23964 in healthy humans, focusing on its effects on immune and inflammatory markers.", "results_summary": "The study found no persistent side effects, no changes in hematological parameters, inflammatory markers, or liver enzyme values, and invalidated minor immune activity changes observed in the pilot study.", "population_specificity": "Healthy human volunteers", "effective_dosage": "Up to 8.5\u00d710^11 cells (pilot study) and up to 10^12 cells (major study) daily", "study_duration": "3 weeks (pilot study) and 6 weeks (major study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:54.817890+00:00"}
{"study_id": 189336, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether MK-7-enriched olive oil increases plasma MK-7 levels and affects osteocalcin carboxylation status, which involves glutamate residues.", "results_summary": "MK-7-enriched olive oil significantly and dose-dependently increased plasma MK-7 levels and improved the carboxylation status of osteocalcin, evidenced by increased carboxylated osteocalcin (cOC) and decreased undercarboxylated osteocalcin (ucOC).", "population_specificity": "Healthy young volunteers (n=12)", "effective_dosage": "45 \u03bcg and 90 \u03bcg MK-7 daily", "study_duration": "2 weeks per dosage phase (total 6 weeks including washout)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:54.894305+00:00"}
{"study_id": 189338, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 65, "study_goal": "The researchers aimed to determine if glutamine supplementation could enhance peak oxygen uptake (V(O2) peak), oxygen uptake at lactate threshold, and pulmonary oxygen uptake kinetics in COPD patients.", "results_summary": "The study found that oral glutamine supplementation had no significant effect on peak oxygen uptake, oxygen uptake at lactate threshold, or oxygen uptake kinetics in COPD patients.", "population_specificity": "13 patients (9 males, age 66\u00b15 years) with severe COPD (mean FEV(1) 0.88\u00b10.23l, 33\u00b17% predicted).", "effective_dosage": "0.125 g/kg body mass of glutamine in 5 ml/kg body mass placebo.", "study_duration": "Single-dose administration prior to exercise.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:56.171632+00:00"}
{"study_id": 189334, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether daily vitamin K(2) supplementation improves the bioactivity of vitamin K-dependent proteins, including those involving glutamate carboxylation, in hemodialysis patients.", "results_summary": "The study found that vitamin K(2) supplementation significantly reduced levels of inactive vitamin K-dependent proteins (dephosphorylated-uncarboxylated MGP, uncarboxylated osteocalcin, and PIVKA-II) in a dose- and time-dependent manner, indicating improved vitamin K status. Response rates were notably high at higher dosages (77% and 93% for 135 \u03bcg and 360 \u03bcg, respectively).", "population_specificity": "53 long-term hemodialysis patients in stable conditions, aged 18 or older, compared to 50 healthy age-matched controls.", "effective_dosage": "45 \u03bcg, 135 \u03bcg, or 360 \u03bcg of menaquinone-7 (vitamin K(2)) daily.", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:56.433106+00:00"}
{"study_id": 189340, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to examine the effect of L-ornithine hydrochloride ingestion on ammonia metabolism and exercise performance, including its impact on plasma glutamate concentrations.", "results_summary": "Plasma glutamate concentrations were significantly higher after exhaustion with ornithine ingestion compared to placebo, suggesting an influence on ammonia buffering, though no performance improvement was observed.", "population_specificity": "14 healthy young adults (age: 22.2\u00b11.0 years) who trained regularly.", "effective_dosage": "0.1 g/kg body mass of L-ornithine hydrochloride.", "study_duration": "Single ingestion before exercise.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:57.754197+00:00"}
{"study_id": 189339, "supplement_id": 1158, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to investigate the physiological and metabolic effects of monosodium glutamate (MSG) in healthy adults during the postprandial phase.", "results_summary": "MSG supplementation (2 g) increased gastric distension and elevated plasma levels of several indispensable amino acids in the early postprandial phase, but did not affect glucose, insulin, GLP-1, ghrelin, hunger, fullness, or dietary nitrogen fate compared to the control.", "population_specificity": "Thirteen healthy adults.", "effective_dosage": "2 g of MSG per day.", "study_duration": "6 days of supplementation, with postprandial examination on the 7th day.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:57:58.189845+00:00"}
{"study_id": 189341, "supplement_id": 1158, "safety_score": "90", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine the effects of creatine supplementation on brain metabolites, specifically glutamate, in ALS patients.", "results_summary": "Higher dosages of creatine were associated with a 17% decrease in glutamate + glutamine signals in the brain, suggesting a potential modulatory effect on glutamate levels. No safety concerns were reported at any dosage.", "population_specificity": "Six participants with amyotrophic lateral sclerosis (ALS).", "effective_dosage": "5, 10, and 15 g twice daily (b.i.d.).", "study_duration": "Three weeks (escalating dosages weekly).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:03.002432+00:00"}
{"study_id": 189343, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of glutamate in Alzheimer's disease, focusing on how astrocytes' dysfunction in glutamate uptake and conversion contributes to neurodegeneration.", "results_summary": "The study suggests that in Alzheimer's disease, reactive astrocytes neglect their neurosupportive functions, including glutamate uptake, leading to neuronal vulnerability. It proposes that restoring astrocyte function could be a therapeutic target.", "population_specificity": "Not specified (focus on Alzheimer's disease pathology).", "effective_dosage": "Not available.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:03.599142+00:00"}
{"study_id": 189342, "supplement_id": 1158, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether supplementation with cystine and theanine (a precursor of glutamate) could mitigate the attenuation of natural killer cell activity (NKCA) during high-intensity resistance exercise.", "results_summary": "The study found that high-intensity and high-frequency resistance exercises reduced NKCA in the placebo group, but this attenuation was restored with CT supplementation. No significant changes were observed in other immune variables (IgM, IL-6, IL-8, salivary IgA, leukocyte count) in either group.", "population_specificity": "15 well-trained men (aged 22.8 \u00b1 4.0 years).", "effective_dosage": "CT group received cystine (700 mg) and theanine (280 mg) once daily; placebo group received cellulose (950 mg) and glutamate (30 mg) once daily.", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:05.287485+00:00"}
{"study_id": 14912, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of glutamine metabolism in tumor growth, spread, immune regulation, and its potential as a target for anti-cancer therapies.", "results_summary": "Glutamine was found to enhance cancer cell growth, spread, and drug resistance in some tumors while inhibiting proliferation in others (e.g., pancreatic cancer and melanoma), with effects linked to immune microenvironment regulation. The study also reviewed clinical progress in glutamine-targeted therapies and their combination with existing treatments.", "population_specificity": "Tumor cells (in vitro or animal models implied) and clinical research contexts (specific human populations not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:05.573202+00:00"}
{"study_id": 14914, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine if Bacillus coagulans-198 (BC198) could mitigate gut microbiota imbalance and mucositis caused by 5-fluorouracil, with or without L-glutamine.", "results_summary": "The study found that BC198 maintained a healthy gut microbiota and reduced intestinal inflammation, regardless of L-glutamine use, suggesting it can help counteract 5-FU-induced gut deterioration.", "population_specificity": "Cancer patients undergoing 5-fluorouracil treatment.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:05.652712+00:00"}
{"study_id": 14915, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the impact of radiation on glioma-associated macrophages (GAMs) polarization and the role of glutamine synthetase (GS) in promoting tumor progression.", "results_summary": "The study found that radiation promoted GAMs' pro-tumorigenic M2 polarization via GS upregulation, fostering glioma progression, while GS inhibition with MSO shifted macrophages to an anti-tumor M1 phenotype and enhanced anti-tumor immunity when combined with radiation.", "population_specificity": "Murine orthotopic glioma models and macrophages co-cultured with glioma cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:07.320172+00:00"}
{"study_id": 14911, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to determine if adding L-glutamine (L-G) and hyaluronic acid (HA) to photobiomodulation (PBM) and the Preventive Oral Care Protocol (POCP) would improve the prevention and control of severe oral mucositis (OM) compared to PBM + POCP alone.", "results_summary": "The combination of PBM + POCP + L-G + HA resulted in significantly lower severity of OM according to the WHO scale at the 30th radiotherapy session, with group B (L-G + HA) showing fewer severe OM cases and better quality of life outcomes than group A (PBM + POCP alone). No differences were observed using the NCI scale.", "population_specificity": "Patients with head and neck cancer undergoing radiochemotherapy (RCT).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Assessments were made at the 1st, 7th, 14th, 21st, and 30th radiotherapy sessions.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:07.909656+00:00"}
{"study_id": 14918, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether glutamine supplementation could enhance rotator cuff healing by mitigating age-related osteoporosis in elderly rats.", "results_summary": "Glutamine supplementation improved bone quality, enhanced tissue regeneration, and increased the resilience of the tendon-bone complex in aged rats with rotator cuff tears.", "population_specificity": "Female Sprague-Dawley rats (aged and young)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:12.436158+00:00"}
{"study_id": 14919, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of glutamine metabolism in immune cell behavior and its impact on immunotherapy outcomes.", "results_summary": "The abstract suggests that glutamine metabolism influences immune cell activity and may affect responses to immunotherapy, but specific results or clinical outcomes are not detailed.", "population_specificity": "Not specified (general discussion of immune cells and immunotherapy).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:12.602649+00:00"}
{"study_id": 14916, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the role of LOX-1 in liver fibrosis progression and its mechanism involving glutamine metabolism reprogramming.", "results_summary": "LOX-1 exacerbated liver fibrosis by promoting hepatic stellate cell activation and reprogramming glutamine metabolism via the LOX-1/OCT1/GLS1 axis. LOX-1 deletion reversed fibrosis development and rewired ammonia metabolism by regulating glutamine metabolism-urea cycle.", "population_specificity": "Patients and rodents with liver fibrosis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:12.672433+00:00"}
{"study_id": 14917, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the efficacy of a PET imaging platform using [11C]Gln for tracking glutaminolysis responses to GLS1 inhibition in NASH mice.", "results_summary": "The study found that [11C]Gln PET imaging effectively tracked glutamine metabolism, showing increased hepatic uptake in NASH mice and reduced uptake after BPTES treatment, correlating with improved liver damage.", "population_specificity": "Methionine and choline deficient (MCD)-fed NASH mice.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:13.278645+00:00"}
{"study_id": 14920, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine if inhibiting glutamine metabolism using CB-839 and BSO, delivered via a hafnium-based metal-organic framework, could enhance the efficacy of radio-immunotherapy in MYC-amplified hepatocellular carcinoma (HCC).", "results_summary": "The study found that UiO66-Hf(2OH)-C/B@HA synergistically inhibited glutamine metabolism, alleviated tumor hypoxia, and triggered immunogenic cell death, enhancing the efficacy of radio-immunotherapy in MYC-amplified HCC. Combination with immune checkpoint blockade further improved outcomes, increasing T cell infiltration and tumor regression.", "population_specificity": "Orthotopic HCC model with MYC-amplified tumor cells.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:16.203805+00:00"}
{"study_id": 14921, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to understand the role of glutamine metabolism in cervical cancer by identifying prognostic genes and assessing their impact on survival, immune response, and drug sensitivity.", "results_summary": "The study identified four glutamine metabolism-related genes (UCP2, LEPR, TFRC, RNaseH2A) and developed a prognostic model with strong predictive performance for survival and immune infiltration in cervical cancer patients. Low-risk patients showed significantly better survival outcomes than high-risk patients.", "population_specificity": "Women with cervical cancer (data sourced from TCGA, GTEx, and GEO databases).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:16.697668+00:00"}
{"study_id": 14922, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the therapeutic efficacy of L-glutamine (L-Gln) on osteoarthritis (OA) progression and symptoms, comparing it to glucosamine sulfate (GS) and celecoxib (CXB).", "results_summary": "L-Gln reduced serum cartilage degradation markers, improved knee joint cartilage destruction, and decreased osteophyte formation in rats. In clinical trials, L-Gln showed comparable efficacy to GS and CXB in improving pain, physical function, and OA symptoms, with no significant differences between the groups.", "population_specificity": "Rats with induced OA and human patients with mild primary OA.", "effective_dosage": "Not specified in the abstract.", "study_duration": "8 weeks for rats, 12 weeks for humans.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:17.214833+00:00"}
{"study_id": 14923, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to identify how glutamine signals within cells and its role in tumorigenesis, particularly through the OTUD4/LDHA axis.", "results_summary": "Glutamine binds to HSC70, stabilizing LDHA via the microautophagy-lysosome pathway, increasing lactate production and reducing IFN-\u03b2 expression. Depleting glutamine or inhibiting its transport synergized with chemotherapy to enhance IFN-\u03b2 activation, CD8+ T cell recruitment, and cancer growth inhibition.", "population_specificity": "Cancer cell lines, patient-derived organoids, and xenografts.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:21.347328+00:00"}
{"study_id": 14925, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether plastidic glutamine synthetase (GS2) improves nitrogen metabolism, biomass, and protein production in plants cultivated with urea.", "results_summary": "Overexpressing GS2 in duckweed increased biomass by 10% and protein content by 24%, while silencing GS2 reduced these traits. Similar enhancements were observed in rice, tobacco, and Arabidopsis under urea cultivation.", "population_specificity": "Duckweed strains (LpZH0104 and Lp9595), rice, tobacco, and Arabidopsis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:21.647512+00:00"}
{"study_id": 14926, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether glutamine could mitigate histamine-induced damage to the rumen epithelial barrier in yak rumen epithelial cells (YRECs) and explore the underlying mechanisms.", "results_summary": "Glutamine reversed histamine-induced downregulation of tight junction proteins (ZO-1, JAM-A, Claudin-1, Claudin-4) at both mRNA and protein levels, restored ZO-1 distribution, and regulated the p38 MAPK signaling pathway and apoptosis.", "population_specificity": "Yak rumen epithelial cells (YRECs)", "effective_dosage": "8 mM glutamine for 12 hours", "study_duration": "12 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:22.143655+00:00"}
{"study_id": 14927, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to develop an injectable peptide gel that modulates glutamine metabolism and enhances chemodynamic therapy to reduce glioblastoma multiforme (GBM) tumor recurrence and improve survival.", "results_summary": "The study found that the peptide gel, combined with glutaminase inhibitor CB-839 and copper peptide particles, enhanced chemodynamic therapy efficacy, increased oxidative stress, and promoted immunogenic cell death in GBM cells, potentially reducing tumor recurrence and improving survival in murine models.", "population_specificity": "Murine models with glioblastoma multiforme (GBM).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:24.904942+00:00"}
{"study_id": 14924, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the effects of glutamine synthetase (GS) and GS-deficient mutations (R324C and K241R) on cancer cell metabolism, particularly under glutamine-deprived conditions.", "results_summary": "The study found that GS deficiency suppresses key metabolic pathways, including DNA synthesis, the citric acid cycle, and ROS detoxification, while activating alternative amino acid biosynthesis pathways. GS mutants also upregulated glutamine transporters and stress-response genes, highlighting metabolic plasticity in cancer cells.", "population_specificity": "Cancer cell lines (H1299, Hepa1-6, LN-229)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:25.483989+00:00"}
{"study_id": 14929, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the synergistic effects of glutamine metabolic reprogramming (via DON prodrugs) combined with sonodynamic therapy (SDT) to enhance antitumor efficacy and remodel the tumor microenvironment.", "results_summary": "The study found that glutamine metabolic disruption via DON amplified SDT-mediated oxidative stress, increased tumor sensitivity to ROS, and induced robust immunogenic cell death, enhancing antitumor effects and remodeling the immunosuppressive tumor microenvironment.", "population_specificity": "Tumor models (specific type not specified in the abstract).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:26.035732+00:00"}
{"study_id": 14928, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the metabolic effects of heptanoate and octanoate on TCA cycle activity, including their impact on glutamine-derived carbon influx.", "results_summary": "The study found that heptanoate and octanoate increased the influx of glutamine-derived carbon into the TCA cycle while decreasing glucose-derived carbon contribution, suggesting altered metabolic pathways. Additionally, changes in redox homeostasis and increased serine biosynthesis were observed.", "population_specificity": "HEK293 T cells (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:28.676677+00:00"}
{"study_id": 14933, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate how glutamine deprivation affects cancer cells' response to IFN-\u03b3 and whether targeting glutamine metabolism could improve immunotherapy efficacy.", "results_summary": "Glutamine deprivation reduced IFN-\u03b3-driven responses in cancer cells, making tumors resistant to anti-PD-1/PD-L1 therapy, while V9302 (an ASCT2 inhibitor) enhanced IFN-\u03b3 responses and improved immunotherapy efficacy by inhibiting autophagy and lysosomal activity.", "population_specificity": "Human lung cancer cell lines, patient-derived tumor explants, and a syngeneic mouse model of lung cancer.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:31.234657+00:00"}
{"study_id": 14931, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the anti-cancer effects of combining trametinib (a MEK1/2 inhibitor) with V-9302 (a glutamine transporter inhibitor) in KRAS-mutant NSCLC, focusing on glutamine utilization.", "results_summary": "The combination of trametinib and V-9302 showed potent synergistic antitumor effects, inducing cell cycle arrest and pyroptosis, reducing glutamine metabolism, and enhancing ROS generation while decreasing GSH synthesis and ATP levels. In vivo, the combination significantly inhibited tumor growth compared to single-agent treatments.", "population_specificity": "KRAS-mutant non-small-cell lung cancer (NSCLC) cells and a xenograft mouse model.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:31.684604+00:00"}
{"study_id": 14934, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if missense suppression of glutamine codons with serine or alanine could reduce polyQ protein aggregation in Huntington's disease.", "results_summary": "The study found that tRNASer CUG reduced polyQ protein production and aggregate formation, while tRNAAla CUG selectively decreased insoluble aggregates by 2-fold, with no cytotoxic effects or disruption of global protein synthesis.", "population_specificity": "Neuroblastoma cells", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:32.528393+00:00"}
{"study_id": 14930, "supplement_id": 1159, "safety_score": "70", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the combination of glutamine metabolism inhibition (via CB-839) with EGFR inhibition (via panitumumab) to identify biomarkers and improve outcomes in KRAS wild-type metastatic colorectal cancer patients.", "results_summary": "The combination was tolerable with manageable side effects, showing a 41% disease control rate (partial response and stable disease). The \"B-score\" correlated with clinical benefit and tumor glutamine avidity, suggesting potential as a biomarker.", "population_specificity": "Patients with KRAS wild-type metastatic colorectal cancer who had prior anti-EGFR treatment progression.", "effective_dosage": "CB-839 (600 mg/kg or 800 mg/kg) and panitumumab (6 mg/kg).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:32.574551+00:00"}
{"study_id": 14936, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine how BET inhibition affects glutamine metabolic remodeling in liver cancer cells and whether targeting this pathway could be therapeutically beneficial.", "results_summary": "BET inhibition enhanced mitochondrial glutamine oxidative metabolism by downregulating miR-30a and upregulating GDH1, leading to increased \u03b1-ketoglutarate production for OXPHOS. Combined BET and OXPHOS inhibition effectively prevented liver tumor growth in vitro and in vivo.", "population_specificity": "Liver cancer cells and tumor models (in vitro and in vivo)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:34.685657+00:00"}
{"study_id": 14935, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine how glutamine dependency in pancreatic ductal adenocarcinoma (PDAC) influences metabolic adaptation and susceptibility to ferroptosis under glutamine restriction or antagonism.", "results_summary": "The study found that glutamine restriction or treatment with the glutamine antagonist DON inhibited PDAC growth and activated ferroptosis. Epigenetic remodeling via Paxip1 upregulated H3K4me3 and Hmox1, while adaptive increases in ferroptosis repressors (e.g., Slc7a11, Gpx4) sensitized PDAC cells to ferroptosis upon glutamine deprivation. Combining DON with GPX4 inhibitors enhanced ferroptosis in vitro and in PDX models.", "population_specificity": "Pancreatic ductal adenocarcinoma (PDAC) cells and patient-derived xenografts (PDXs).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:36.527162+00:00"}
{"study_id": 14937, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the anti-tumor efficacy and immune-modulating effects of the glutamine antagonist JHU083 in immunocompetent murine models of gynecological cancers.", "results_summary": "JHU083 demonstrated significant anti-tumor efficacy, reducing tumor burden and progression while selectively suppressing immunosuppressive M2-like macrophages and sparing pro-inflammatory M1-like macrophages, leading to an immune-stimulatory microenvironment.", "population_specificity": "Immunocompetent murine models of gynecological cancers.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:37.156177+00:00"}
{"study_id": 14941, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine how glutamine, glycine, and serine influence cisplatin sensitivity in gastric cancer cells and the underlying molecular mechanisms.", "results_summary": "Glutamine, glycine, and serine were found to regulate cisplatin sensitivity in gastric cancer cells by modulating KDM4A acetylation and ubiquitination, with higher concentrations enhancing chemotherapy sensitivity.", "population_specificity": "Gastric cancer cells (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:40.013288+00:00"}
{"study_id": 14938, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the therapeutic potential of RA-PF, a glutamine derivative, in targeting multiple pathological aspects of Alzheimer's disease (AD) in mouse models.", "results_summary": "RA-PF treatment reduced A\u03b2 plaque deposition, inhibited microglial activation, restored synaptic transmission, improved mitochondrial motility, and alleviated anxiety-like behaviors and tau phosphorylation in AD mouse models. Transcriptomic analysis indicated recovery of key signaling pathways related to inflammation and synaptic function.", "population_specificity": "5xFAD and 3xTg-AD mice (Alzheimer's disease models).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:40.358008+00:00"}
{"study_id": 14939, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of glutamine metabolic reprogramming in pancreatic cancer progression and its potential as a therapeutic target.", "results_summary": "The study found that pancreatic cancer cells exhibit unique glutamine metabolism, particularly through non-canonical pathways, which supports their survival and proliferation by affecting redox homeostasis. Targeting these pathways may offer new therapeutic opportunities for pancreatic cancer treatment.", "population_specificity": "Pancreatic cancer cells (in vitro or preclinical models, not explicitly specified).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:40.946111+00:00"}
{"study_id": 14940, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the role of glutamine metabolism in dry eye disease (DED) and assess its therapeutic potential when combined with mesenchymal stem cells (MSCs) and thymosin beta-4 (T\u03b24).", "results_summary": "The study found that glutamine levels increased in the cornea following combined MSC and T\u03b24 therapy, and inhibition of glutamine reversed anti-inflammatory and anti-apoptotic effects. Glutamine treatment downregulated pro-inflammatory and pro-fibrotic corneal epithelial cells, reducing inflammation and apoptosis via the I\u03baB\u03b1/NF-\u03baB signaling pathway.", "population_specificity": "Rodent models and clinical cases of dry eye disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:41.984271+00:00"}
{"study_id": 14943, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to understand how Mycobacterium abscessus (Mab) infection alters macrophage energy metabolism, particularly focusing on glutamine dependency and flexibility.", "results_summary": "The study found that Mab infection modulates mitochondrial substrate preferences, with R-type Mab infections showing decreased glutamine reliance but enhanced metabolic flexibility. Targeting glutamine-related pathways exacerbated Mab growth, suggesting these pathways play a protective role against infection.", "population_specificity": "Murine bone marrow-derived macrophages (BMDMs)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:44.106992+00:00"}
{"study_id": 14942, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to examine the role of SPC25 in glutamine metabolism and its impact on immune escape in lung adenocarcinoma (LUAD).", "results_summary": "The study found that SPC25 overexpression enhances glutamine metabolism, promoting immune escape in LUAD, which could be mitigated by GPNA therapy. E2F8 was identified as a transcription factor regulating SPC25, further influencing glutamine metabolism and immune escape.", "population_specificity": "Lung adenocarcinoma (LUAD) cells and associated immune cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:44.272448+00:00"}
{"study_id": 14944, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the anticancer properties of glutamine analogs Acivicin and Azaserine in breast cancer cells, focusing on their effects on glutamine metabolism and apoptosis.", "results_summary": "Acivicin and Azaserine inhibited MCF-7 breast cancer cell proliferation without harming normal cells, reduced glutamine synthetase expression, and promoted apoptosis and anti-inflammatory cytokine production.", "population_specificity": "Breast cancer MCF-7 cell line and non-tumorigenic MCF-10 epithelial cell line (in vitro).", "effective_dosage": "Lower concentrations (specific amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:46.910656+00:00"}
{"study_id": 14947, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether a glutamine-enriched peptide diet could reduce gastrointestinal toxicity and treatment interruptions in rectal cancer patients undergoing neoadjuvant chemo-radiotherapy compared to dietary advice alone.", "results_summary": "The glutamine-enriched peptide diet reduced the risk of diarrhea and mucositis during treatment and decreased radiotherapy interruptions, particularly in stage III and malnourished patients.", "population_specificity": "Patients with rectal cancer undergoing neoadjuvant chemo-radiotherapy.", "effective_dosage": "Not specified", "study_duration": "From the beginning of radiotherapy until surgery (exact duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:48.648306+00:00"}
{"study_id": 14945, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether agents preventing nitration or facilitating denitration of glutamine synthetase (GS) could serve as new antidepressants and treat GS-related diseases like epilepsy and hyperammonemia.", "results_summary": "Tyrosine (Tyr) and tyrosyl-glutamine (YQ) protected GS activity against nitration, exerted antidepressant effects in stressed mice, reduced seizures in epilepsy models, and lowered blood ammonia levels in hyperammonemia models by enhancing GS activity through Tyr-denitration.", "population_specificity": "Mice (chronic immobilization stress depression model, kainic acid-induced seizures model, azoxymethane- or bile duct ligation-induced hyperammonemia models)", "effective_dosage": "Tyr (0.0313-0.5 \u00b5M)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:50.279348+00:00"}
{"study_id": 14948, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop a folate-targeted nanoparticle therapy to inhibit glutamine metabolism in ovarian cancer cells while minimizing toxicity to normal tissues and enhancing the anti-tumor immune response.", "results_summary": "The study found that folate-targeted nanoparticles (FA-DCNPs) co-encapsulating DON and CaCO3 effectively suppressed tumor cell proliferation by disrupting glutamine metabolism and inducing calcium overload. Additionally, FA-DCNPs modulated the tumor immune microenvironment by reducing M2-TAMs activity and promoting M1-TAMs polarization.", "population_specificity": "Ovarian cancer (OC) patients and tumor-associated macrophages (TAMs).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:50.810092+00:00"}
{"study_id": 14950, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to understand the impact of tumor-driven glutamine uptake on immune cells and explore the potential synergy between glutamine supplementation and immunotherapy.", "results_summary": "The study found that tumor-driven glutamine consumption disrupts immune cell function and metabolic balance, but glutamine supplementation may enhance immunotherapy efficacy in cancer treatment.", "population_specificity": "Tumor microenvironment and immune cells (not specified if human or animal models).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:51.703372+00:00"}
{"study_id": 14951, "supplement_id": 1159, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antileukemic potential and MMP-2 inhibitory effects of newly synthesized p-tosyl-D(-)-glutamine derivatives for treating chronic myeloid leukemia (CML).", "results_summary": "The lead compounds 5g and 5j demonstrated strong antileukemic effects, effectively inhibiting MMP-2 and MMP-9, inducing apoptosis, and showing antiangiogenic properties without harming normal cells.", "population_specificity": "Chronic myeloid leukemia (CML) cell lines (K562 and ACHN).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:53.024908+00:00"}
{"study_id": 14952, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the role of glutamine uptake in colorectal cancer liver metastasis (CRLM) and its regulation by the PWAR6/NRF2/SLC38A2 signaling axis.", "results_summary": "The study found that PWAR6 upregulates SLC38A2, enhancing glutamine uptake in CRC cells and depleting glutamine availability for NK cells, promoting immune evasion and metastasis. Targeted inhibition of PWAR6 combined with FAPI treatment effectively reduced metastasis in preclinical models.", "population_specificity": "Patients with colorectal cancer liver metastasis (CRLM).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:55.823571+00:00"}
{"study_id": 14953, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the role of the glutamine-\u03b1KG axis in osteo/odontogenic differentiation of dental-pulp-derived mesenchymal adult stem cells (m-ASCs) and its potential for dental tissue repair.", "results_summary": "The study found that the glutamine-\u03b1KG axis promotes osteo/odontogenic differentiation of m-ASCs and accelerates dentin formation in mice. Inhibition of this axis reduced differentiation, which was rescued by \u03b1KG supplementation, suggesting an epigenetic mechanism involving m6A methylation and IGF2 translation.", "population_specificity": "Dental-pulp-derived mesenchymal adult stem cells (m-ASCs) and a murine incisor clipping model.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:56.582256+00:00"}
{"study_id": 14954, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine how GPER-mediated glutamine production by cancer-associated fibroblasts (CAFs) influences triple-negative breast cancer (TNBC) cell viability, motility, and chemoresistance.", "results_summary": "The study found that estrogen-activated GPER in CAFs upregulates glutamine synthetase (GLUL) and lactate dehydrogenase B (LDHB), increasing glutamine production, which TNBC cells absorb and metabolize to enhance tumor progression and chemoresistance.", "population_specificity": "Triple-negative breast cancer (TNBC) cells and cancer-associated fibroblasts (CAFs) in vitro and in vivo.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:57.802163+00:00"}
{"study_id": 14957, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the role of the METTL16/GOT2/glutamine axis in smoking-induced COPD and assess the potential therapeutic value of glutamine in reducing chronic airway inflammation.", "results_summary": "The study found that glutamine supplementation significantly reduced inflammation levels in a 3-month COPD murine model, with METTL16 regulating lung epithelial mitochondrial function by reprogramming glutamine metabolism.", "population_specificity": "COPD murine model (mice) and lung epithelial cells exposed to cigarette smoke extract (CSE).", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:59.333990+00:00"}
{"study_id": 14949, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to identify key genes associated with glutamine metabolism in lung adenocarcinoma and develop a risk model to predict patient outcomes and potential therapeutic targets.", "results_summary": "The study identified ALDH18A1 as a prognostic hub gene linked to poor clinical outcomes and worse survival, constructed a robust nomogram with high predictive accuracy (AUC > 0.8), and highlighted glutamine metabolism's role in cancer progression and immune suppression.", "population_specificity": "Patients with lung adenocarcinoma.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:59.756188+00:00"}
{"study_id": 14955, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of glutamine, alone and in combination with lactic acid, on growth performance, nutrient digestibility, intestinal health, and microflora in weaning piglets.", "results_summary": "Glutamine supplementation improved feed intake, nutrient digestibility, digestive enzyme activity, intestinal barrier function, and gene expressions related to intestinal development. It also showed synergistic effects with lactic acid in enhancing these outcomes.", "population_specificity": "24-day-old weaning piglets (Duroc \u00d7 Landrace \u00d7 Yorkshire).", "effective_dosage": "1% glutamine in diet.", "study_duration": "28 days.", "interactions": "Positive interactive effects with lactic acid were noted.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:58:59.757577+00:00"}
{"study_id": 14959, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the role of glutaminase enzymes (GLS and GLS2) in coronavirus replication and whether their inhibition could block viral infection.", "results_summary": "The study found that glutaminase enzymes are upregulated during coronavirus infection and that their genetic silencing or pharmacological inhibition (using SU1 and UP4) reduces viral replication in epithelial cells and improves survival in SARS-CoV-2-infected mice.", "population_specificity": "Human epithelial cells and K18-human ACE2 transgenic mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:01.372578+00:00"}
{"study_id": 14958, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the anticancer effects of platinum nanoparticles functionalized with glutamine and conjugated with thiosemicarbazone (TSC) on the MDA-MB-231 breast cancer cell line.", "results_summary": "Pt@Gln-TSC nanoparticles showed significantly higher toxicity to breast cancer cells (IC50 = 170 \u00b5g/ml) than to normal cells (IC50 = 348 \u00b5g/ml), increased necrosis and apoptosis, and elevated CASP-8 gene expression by 2.54-fold, indicating activation of extrinsic apoptosis.", "population_specificity": "MDA-MB-231 breast cancer cell line and HDF normal cell line.", "effective_dosage": "IC50 values: 170 \u00b5g/ml for MDA-MB-231, 348 \u00b5g/ml for HDF.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:02.078726+00:00"}
{"study_id": 14961, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the role of glutamine metabolism in rotavirus (RV) replication and its potential as a therapeutic target against RV infection.", "results_summary": "The study found that RV replication depends on glutamine metabolism, which generates glutamate, aspartate, and asparagine to facilitate infection. Inhibiting aspartate biogenesis from glutamine using Aminooxyacetic acid (AOAA) significantly reduced RV infection in vitro and in vivo.", "population_specificity": "Human intestinal epithelial cells (HT-29) and in vivo models (specifics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:04.610352+00:00"}
{"study_id": 14963, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of glutamine deprivation on cellular metabolism and drug sensitivity in human glioblastoma cell lines.", "results_summary": "Glutamine deprivation reduced cell growth rates and induced metabolic shifts (glycolysis in U87MG cells, oxidative phosphorylation in T98G cells), altering drug sensitivity profiles (increased DR5-B sensitivity in U87MG, resistance in T98G; opposite effects for GMX1778).", "population_specificity": "Human glioblastoma cell lines (U87MG and T98G).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:06.254426+00:00"}
{"study_id": 14962, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether targeting glutamine synthetase (GS) via a CRISPR/Cas9 delivery system could inhibit choroidal neovascularization (CNV) in wet age-related macular degeneration (wAMD).", "results_summary": "The study found that the AS1411-modified exosome-liposome hybrid nanoparticle (CAELN) system effectively edited the GLUL gene, reducing GS levels and suppressing CNV in vitro and in vivo, with gene editing efficiencies of 42.05\u201355.02% and restoration of tissue thickness in CNV rabbits.", "population_specificity": "Rabbits with induced CNV and HUVEC cells (human umbilical vein endothelial cells).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:06.605942+00:00"}
{"study_id": 14965, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to explore glutamine's role in metabolic reprogramming of pancreatic cancer cells and develop a targeted ferroptosis therapy using a glutamine-modified iron-delivery system.", "results_summary": "The study found that glutamine modification enhanced endocytic uptake of the iron-delivery system in pancreatic cancer cells, and combining it with the glutamine transporter inhibitor V9302 further improved uptake and induced ferroptosis in tumor models.", "population_specificity": "Pancreatic cancer cells and mice pancreatic tumor models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:08.214335+00:00"}
{"study_id": 14964, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of glutamine metabolism, particularly through HAO1 and SLC transporters, in luminal breast cancer prognosis and its potential as a therapeutic target.", "results_summary": "High HAO1 protein expression was associated with poor prognosis in luminal breast cancer, while high mRNA expression correlated with better survival, suggesting complex regulatory mechanisms. HAO1's interaction with SLC transporters (SLC1A5 and SLC7A5) highlights its potential role in glutamine metabolism and as a therapeutic target.", "population_specificity": "Women with luminal (ER+) breast cancer.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:08.249909+00:00"}
{"study_id": 14966, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the role of SLC38A5-mediated glutamine transport in osteosarcoma progression and its underlying mechanisms.", "results_summary": "SLC38A5 upregulation promotes osteosarcoma cell proliferation, migration, and invasion via glutamine-mediated activation of the PI3K/AKT/mTOR pathway and inhibition of ferroptosis. Silencing SLC38A5 or using a PI3K inhibitor (BKM120) counteracted these effects.", "population_specificity": "Osteosarcoma cells and a subcutaneous xenograft tumor model in nude mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:08.940301+00:00"}
{"study_id": 14968, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of L-glutamine metabolism-related genes in AML progression using single-cell RNA sequencing.", "results_summary": "The study found increased glutamine-related activity in CD34+ pre-B cells, suggesting a regulatory role in AML tumorigenesis. It also identified key signaling pathways and 10 genes linked to AML prognosis, with CCL5 and CD52 highlighted as potential therapeutic targets.", "population_specificity": "Acute myeloid leukemia (AML) patients", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:09.269972+00:00"}
{"study_id": 14969, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the impact of glutamine on neutrophil recruitment and effector functions during sterile inflammation.", "results_summary": "Glutamine treatment reduced neutrophil activation by modulating \u03b22-integrin activity and chemotaxis in vitro, attenuated neutrophil recruitment in vivo, and improved mitochondrial functionality and glutathione metabolism. It also decreased reactive oxygen species production and neutrophil extracellular trap formation.", "population_specificity": "Murine model (mice) with sterile inflammation induced by renal ischemia-reperfusion injury.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:10.194567+00:00"}
{"study_id": 14971, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the effects of scutellarein on non-small cell lung cancer (NSCLC) and its underlying mechanisms, particularly its impact on glutamine metabolism.", "results_summary": "Scutellarein altered glutamine metabolism by reducing the expression of key glutamine transporters (ASCT2, LAT1) and glutaminase (GLS1), leading to inhibited tumor growth and induced apoptosis in lung cancer cells.", "population_specificity": "Lewis lung cancer mouse model and A549/H1299 lung cancer cell lines.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:13.071261+00:00"}
{"study_id": 14972, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effect and mechanism of inhibiting glutamine synthetase (GS) on vascular permeability in gliomas.", "results_summary": "Inhibiting GS with MSO increased vascular permeability in gliomas, linked to elevated NO levels and vasodilation. The study found that MSO reduced GS activity, increased glutamate levels, activated NMDA receptors, and raised NOS activity and NO concentrations.", "population_specificity": "C6 glioma rat models", "effective_dosage": "Intraperitoneal injection of MSO once every other day (total of three injections)", "study_duration": "Approximately 6 days (three injections every other day)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:15.215469+00:00"}
{"study_id": 14973, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the antitumor effects of glutamine blockade in bladder cancer and explore the potential of combining glutamine metabolism inhibitors with gefitinib to improve therapeutic outcomes.", "results_summary": "Glutamine blockade using DON and JHU083 inhibited bladder cancer cell growth in vitro and in vivo but prolonged administration led to PD-L1 upregulation and T-cell immunosuppression. Combining JHU083 with gefitinib reversed PD-L1 upregulation, alleviated immunosuppression, and improved therapeutic outcomes.", "population_specificity": "Bladder cancer cells (in vitro) and bladder cancer-bearing mice (in vivo).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Gefitinib (enhanced therapeutic effect when combined with JHU083)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:15.911971+00:00"}
{"study_id": 14974, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anti-cancer potential of glutamine-functionalized zinc oxide nanoparticles (ZnO@Gln-TSC NPs) for gastric cancer treatment.", "results_summary": "The study found that ZnO@Gln-TSC NPs exhibited significant anti-cancer effects, including higher apoptosis rates, increased reactive oxygen species levels, and elevated caspase-3 activity and gene expression in AGS cells. The NPs showed lower IC50 values compared to other treatments, indicating higher efficacy.", "population_specificity": "AGS (gastric carcinoma) cells and HEK293 (human embryonic kidney) cells.", "effective_dosage": "IC50 values: 9.8 \u03bcg/mL for AGS cells, 150.5 \u03bcg/mL for HEK293 cells.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:17.865945+00:00"}
{"study_id": 14978, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether glutamine metabolism regulates NLRP3 inflammasome activation in microglia and its potential role in Alzheimer's disease.", "results_summary": "The study found that increased glutamine metabolism in microglia under AD conditions activates the NLRP3 inflammasome, and inhibiting glutaminase attenuated this activation by promoting mitophagy and reducing oxidative stress.", "population_specificity": "AD mice and cultured inflammatory microglia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:17.934807+00:00"}
{"study_id": 14975, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the potential of d-[5-11C]-Glutamine PET imaging for early detection and treatment monitoring of orthopedic implant infections (OIIs).", "results_summary": "The study found that d-[5-11C]-Gln uptake was significantly higher in infected screws compared to sterile ones, with superior infection-to-background ratios and sensitivity for detecting residual bacterial burden compared to other imaging agents. Post-treatment imaging showed a significant reduction in uptake at infected sites, correlating well with bacterial counts.", "population_specificity": "Rat model with tibial implantation of sterile or S. aureus-colonized stainless-steel screws.", "effective_dosage": "Not specified (tracer used for imaging).", "study_duration": "3 weeks of vancomycin treatment.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:17.995389+00:00"}
{"study_id": 14977, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of liraglutide on diabetic neuropathy in mice, including its impact on pain sensation, inflammatory markers, and the glutamine/glutamate ratio.", "results_summary": "Liraglutide alleviated antinociceptive behavior in diabetic mice, particularly in those reared in an enriched environment, and increased the glutamine/glutamate ratio. It also reduced some inflammatory and oxidative stress parameters.", "population_specificity": "Mice with early-stage type 1 diabetes induced by streptozotocin.", "effective_dosage": "0.4 mg/kg once daily, intraperitoneal.", "study_duration": "10 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:18.410105+00:00"}
{"study_id": 14976, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to identify and characterize the GS and GOGAT gene families in pear species to understand their roles in nitrogen use efficiency (NUE) and response to hormones and abiotic stress.", "results_summary": "The study identified 29 GS and GOGAT genes in pear genomes, showing evolutionary conservation and roles in growth, development, and stress responses. PbeGS1.1, PbeGS2.2, and PbeNADH-GOGATs were highlighted as key candidates for improving NUE under hormone and stress conditions.", "population_specificity": "Pear species (Pyrus betulaefolia, Pyrus pyrifolia, Pyrus bretschneideri).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:19.039447+00:00"}
{"study_id": 14979, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to determine the impact of glutamine supplementation on intestinal permeability, focusing on its role in immune function and nutrient absorption.", "results_summary": "Glutamine supplementation did not significantly affect intestinal permeability overall, but subgroup analysis showed a significant reduction with doses over 30g/day, particularly for durations under 2 weeks.", "population_specificity": "Participants with various health conditions, mean age 46.52 years.", "effective_dosage": "Over 30g/day showed efficacy.", "study_duration": "Less than 2 weeks for significant effects.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:21.164269+00:00"}
{"study_id": 14980, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to identify glutamine metabolism-related genes (GMRGs) involved in gastric cancer (GC) progression and develop a risk model for prognosis and immune checkpoint blockade response prediction.", "results_summary": "The study identified four key genes (MYB, LRFN4, LMNB2, SLC1A5) linked to glutamine metabolism in GC, showing upregulation in tumor tissues and associations with oncogenic pathways and immune response. The risk model demonstrated prognostic value and potential relevance to immune checkpoint therapy resistance.", "population_specificity": "Gastric cancer patients (data from TCGA-STAD and GEO GSE62254 datasets).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:24.983756+00:00"}
{"study_id": 14981, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the association between dietary glutamine supplementation and the CARD11 pathway in the pathogenesis of atopic dermatitis, focusing on Th1 and Th17 cell expression.", "results_summary": "Glutamine supplementation restored Th1 and Th17 responses in CARD11-deficient mice and reduced inflammatory expression in wild-type mice, mediated via the CARD11-mTORC1 signaling pathway. Inhibition of the glutamine transporter ASCT2 reduced Th1 and Th17 responses, suggesting glutamine's role in modulating immune responses in AD.", "population_specificity": "Wild-type and CARD11-deficient mice with house dust mite epidermal-sensitized skin.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:25.294738+00:00"}
{"study_id": 14984, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate how the TFAP2A/NEIL3 axis influences M2 macrophage polarization in liver cancer through glutamine metabolism.", "results_summary": "The study found that NEIL3 promotes M2 macrophage polarization via glutamine metabolism, with high expression in liver cancer. Knockdown of NEIL3 suppressed tumor growth in vivo.", "population_specificity": "Liver cancer cells and xenograft tumor models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:25.767951+00:00"}
{"study_id": 14982, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to identify differentially expressed amino acid metabolites in PROM versus healthy controls and explore glutamine's anti-inflammatory and protective mechanisms in fetal membranes.", "results_summary": "Glutamine was significantly lower in PROM patients, correlated negatively with pathogenic bacteria, reduced inflammatory cytokines and chemokines, inhibited NF-\u03baB signaling, and protected amniotic epithelial cells from autophagy while stimulating proliferation.", "population_specificity": "Pregnant women between 31 and 36 weeks of gestation (50 PROM cases and 50 healthy controls).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:26.467979+00:00"}
{"study_id": 14986, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of glutamine transporters in digestive system malignant tumors (DSMTs) and evaluate potential therapeutic strategies targeting these transporters.", "results_summary": "The study found that glutamine transporters are upregulated in DSMTs, supporting tumor cell proliferation, and their targeted inhibition effectively suppresses tumor growth. It also discussed glutamine transporter-targeting drugs as potential treatments for DSMTs.", "population_specificity": "Digestive system malignant tumors (DSMTs)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:27.028272+00:00"}
{"study_id": 14983, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of a photothermal nanocomposite (PAI@CB839 NPs) combining glutaminase inhibitor CB839 with photothermal therapy for treating triple-negative breast cancer (TNBC).", "results_summary": "The study found that PAI@CB839 NPs effectively disrupted glutamine metabolism, enhanced antitumor immune responses, and inhibited TNBC growth and metastasis when combined with photothermal therapy. The nanocomposite promoted immunogenic cell death and reprogrammed the tumor microenvironment to an \"immune-hot\" state.", "population_specificity": "Triple-negative breast cancer (TNBC) models.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:27.098017+00:00"}
{"study_id": 14985, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to investigate the dynamic expression of glutamine synthetase (GS) during hepatic ischemia-reperfusion injury (IRI) to understand its potential role as an indicator of liver injury and therapeutic target.", "results_summary": "GS expression rapidly decreased in hepatocytes around the central vein after IRI, reaching its lowest point at 6 hours post-reperfusion, and then gradually recovered, indicating GS's sensitivity to IRI.", "population_specificity": "Liver tissue samples from a hepatic ischemia-reperfusion injury model (specific population not detailed).", "effective_dosage": "Not available", "study_duration": "Samples collected at 0.5, 6, and 24 hours post-reperfusion.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:28.964605+00:00"}
{"study_id": 14987, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of glutamine metabolism in breast cancer progression and the effects of BMP9 and KDM4A inhibition on this process.", "results_summary": "The study found that BMP9 inhibits glutamine metabolism in breast cancer cells, reducing \u03b1-KG levels, and that KDM4A silencing of BMP9 enhances glutamine metabolism, promoting tumor progression. Combining exogenous BMP9 with KDM4A inhibitor JIB-04 significantly inhibited breast cancer growth.", "population_specificity": "Breast cancer cells and nude mice with subcutaneous xenograft tumors.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:30.118355+00:00"}
{"study_id": 14989, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of glutamine and its transporter ASCT2 in basal-like breast cancer progression and identify potential regulatory mechanisms involving lipid metabolism.", "results_summary": "The study found that ASCT2-mediated glutamine transport promotes basal-like breast cancer growth by activating lipid metabolism via PPAR\u03b1, and identified C118P as a potential inhibitor of this pathway.", "population_specificity": "Basal-like breast cancer cells (in vitro or animal model, not specified in abstract).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:33.119920+00:00"}
{"study_id": 14990, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the relationship between circulating glutamine levels and idiopathic pulmonary fibrosis (IPF), as well as its potential as a therapeutic target.", "results_summary": "The study found a significant inverse correlation between glutamine levels and IPF risk, suggesting lower glutamine levels may increase IPF risk. Sensitivity analyses confirmed the robustness of these findings without evidence of pleiotropy or heterogeneity.", "population_specificity": "Individuals with idiopathic pulmonary fibrosis (IPF).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:33.420012+00:00"}
{"study_id": 14988, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine how cancer-associated fibroblasts (CAFs) influence prostate cancer (PCa) growth by manipulating glutamine (Gln) metabolism in a co-culture system.", "results_summary": "CAFs increased the proliferation of hormone-sensitive LNCaP cells and clonogenic growth in both LNCaP and castration-resistant C4-2 cells. Gln deprivation and GLS1 inhibition revealed increased dependence on Gln in LNCaP cells, with proteomic and tissue analyses suggesting GLS1 as a therapeutic target.", "population_specificity": "Prostate cancer cell lines (LNCaP and C4-2) and tissue samples from PCa patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:34.447447+00:00"}
{"study_id": 14991, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the role of NUAKs in metabolic reprogramming, particularly glutamine metabolism, during breast cancer progression.", "results_summary": "NUAKs significantly increased glutamine metabolism in triple-negative breast cancer subtypes, enhancing rapid cell proliferation and metastatic potential via mTOR/c-Myc signaling pathways. Inhibition of mTOR blocked these effects, suggesting NUAKs as a potential therapeutic target.", "population_specificity": "Breast cancer tissues and cell lines, particularly triple-negative and luminal subtypes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:34.449005+00:00"}
{"study_id": 14993, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of glutamine metabolism in leukemia diagnosis, treatment, and subtype differentiation, with a focus on acute myeloid leukemia.", "results_summary": "The study found that glutamine metabolism plays a significant role in leukemia progression, remission, and relapse, and targeting its pathways could aid in diagnosis and therapy. Differences in glutamine metabolism among leukemia subtypes may help in accurate diagnosis.", "population_specificity": "Leukemia patients, particularly those with acute myeloid, chronic lymphocytic, and acute lymphoblastic leukemia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:35.497523+00:00"}
{"study_id": 14992, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the role of glutamine-mediated metabolic rewiring in bladder cancer progression, particularly in African American patients, and explore the therapeutic potential of targeting complex I and GLS1.", "results_summary": "The study found that glutamine metabolism drives higher oxidative phosphorylation activity in African American bladder cancer, leading to increased disease progression. Inhibition of GLS1 or complex I components like NDUFB8 reduced mitochondrial respiration and tumor growth.", "population_specificity": "African American and European American patients with bladder cancer.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:35.992270+00:00"}
{"study_id": 14994, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether targeting glutamine metabolism in combination with a ketogenic diet could enhance anti-cancer effects in pancreatic cancer models.", "results_summary": "The study found that a ketogenic diet increased reliance on glutamine-mediated anaplerosis in pancreatic cancer models, and combining glutamine metabolism inhibitors (DON and CB839) with the diet resulted in robust anti-cancer effects.", "population_specificity": "Murine pancreatic cancer models and in vitro metabolic conditions simulating a ketogenic diet.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:37.103939+00:00"}
{"study_id": 14995, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 87, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the potential of SFPQ, a protein associated with glutamine, as a diagnostic biomarker for non-small-cell lung cancer (NSCLC) and other solid cancers.", "results_summary": "The study found that serum SFPQ levels were significantly elevated in patients with NSCLC and other solid cancers, demonstrating high sensitivity (87%) and specificity (94%) in distinguishing cancer patients from non-cancer controls. The newly developed ELISA assay effectively detected SFPQ, suggesting its utility as a diagnostic tool.", "population_specificity": "Patients with non-small-cell lung cancer (NSCLC) and other solid cancers, compared to non-cancer controls.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:39.269586+00:00"}
{"study_id": 14997, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of glutamine in prostate cancer progression, therapy resistance, and its potential as a therapeutic target.", "results_summary": "The study found that prostate cancer cells become highly dependent on exogenous glutamine, and inhibiting glutamine catabolism impedes tumor growth, survival, and sensitizes cells to radiotherapy. Ongoing clinical trials are evaluating glutamine catabolism inhibitors in combination with other therapies.", "population_specificity": "Prostate cancer cells and patients with solid tumors, including prostate cancer.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:41.372575+00:00"}
{"study_id": 14996, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the role of pyruvate carboxylase (PC) in regulating glutamine metabolism via the Wnt/\u03b2-catenin pathway to protect against ischemia-reperfusion injury (IRI) during heart transplantation.", "results_summary": "PC overexpression improved mitochondrial function, reduced oxidative stress and inflammation, and decreased cardiomyocyte apoptosis, while PC knockdown exacerbated IRI by disrupting glutamine metabolism and the Wnt/\u03b2-catenin pathway.", "population_specificity": "Murine (in vivo) and hypoxia-reoxygenation cell models (in vitro).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:41.914517+00:00"}
{"study_id": 14998, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the role of S100A2 in regulating glutamine metabolism and its impact on lung adenocarcinoma (LUAD) metastasis.", "results_summary": "The study found that S100A2 upregulation mediated glutamine metabolism, promoting LUAD metastasis, and that TFAP2A transcriptionally regulated S100A2 expression, further influencing glutamine metabolism and metastasis.", "population_specificity": "Lung adenocarcinoma (LUAD) tissues and cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:42.858259+00:00"}
{"study_id": 14999, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of glutamine metabolic flux in cartilage development and susceptibility to osteoarthritis in offspring exposed to prenatal prednisone.", "results_summary": "The study found that prenatal prednisone exposure (PPE) decreased glutamine metabolic flux, leading to increased oxidative stress, reduced histone acetylation, and impaired cartilage development. Overexpression of PGC-1\u03b1 reversed these effects, suggesting glutamine's role in mitigating PPE-induced cartilage damage.", "population_specificity": "Female offspring exposed to prenatal prednisone during intrauterine development.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:43.117267+00:00"}
{"study_id": 15000, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether inhibiting glutamine metabolism via a novel nanomedicine (Fe-DBEF) could enhance the sensitivity of chemotherapy and chemodynamic therapy in pancreatic cancer.", "results_summary": "The study found that Fe-DBEF nanomedicine effectively inhibited glutamine metabolism, reduced glutathione production, and synergistically enhanced chemotherapy and ROS therapy, leading to improved anti-proliferation effects in pancreatic cancer.", "population_specificity": "Pancreatic cancer cells (in vitro), human organoids, and KPC animal models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:44.161745+00:00"}
{"study_id": 15001, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to identify metabolic targets, including glutamine dependence, in anoikis-resistant melanoma cells to explore new therapeutic strategies for circulating tumor cells (CTCs) and melanoma metastases.", "results_summary": "Anoikis-resistant melanoma cells showed metabolic reprogramming toward oxidative metabolism, relying on glutamine and fatty acids. Inhibitors targeting glutaminase (BPTES) effectively reduced cell viability and colony formation, confirming glutamine's role in sustaining these cells.", "population_specificity": "Anoikis-resistant melanoma cells (in vitro study).", "effective_dosage": "Not specified.", "study_duration": "24 hours (rocking condition).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:45.012201+00:00"}
{"study_id": 15002, "supplement_id": 1159, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine if l-glutamine supplementation could improve mitochondrial dysfunction and symptom severity in patients with LIG3 mutations.", "results_summary": "l-Glutamine supplementation improved growth rate and ATP production in LIG3-mutant fibroblasts and significantly alleviated gastrointestinal and extra-gastrointestinal symptoms in patients after 8 months of treatment.", "population_specificity": "Patients with biallelic LIG3 mutations exhibiting chronic intestinal pseudo-obstruction, leukoencephalopathy, and neurogenic bladder.", "effective_dosage": "6 mmol/L (in vitro); Dipeptiven (parenteral l-glutamine dipeptide) administered according to standard protocols (exact dosage not specified).", "study_duration": "8 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:46.556221+00:00"}
{"study_id": 15003, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to examine the role of glutamine metabolism in the tumor immune microenvironment and prognosis of gastric cancer, and to develop a prognostic risk model based on glutamine metabolism-related genes.", "results_summary": "The study identified two metabolic subtypes of gastric cancer and developed a prognostic risk model showing that high-risk patients had poorer prognosis, increased immune checkpoint expression, and poor response to chemotherapy. The model was validated as an independent prognostic factor.", "population_specificity": "Patients with gastric cancer (data sourced from TCGA and GEO databases).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:48.095928+00:00"}
{"study_id": 15004, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of glutamine depletion (via asparaginase treatment) on cell cycle perturbation and DNA synthesis in adenocarcinoma cell lines.", "results_summary": "Glutamine shortage, induced by asparaginase, disrupted cell cycle progression and DNA synthesis in 786-O and A549 cells, with recovery observed upon glutamine reintroduction. MCF-7 cells showed no significant cell cycle changes but increased ASNS and GS expression.", "population_specificity": "Adenocarcinoma cell lines (A549, MCF-7, 786-O).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:50.394681+00:00"}
{"study_id": 15007, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the role of glutamine metabolism in colorectal cancer (CRC) progression, specifically how YTHDF1 and its downstream target GID8 regulate glutamine uptake and metabolism.", "results_summary": "The study found that GID8, regulated by YTHDF1, promotes glutamine uptake and metabolism via SLC1A3 and GLS, driving CRC malignancy. Inhibition of GID8 reduced CRC proliferation and metastasis in vitro and in vivo.", "population_specificity": "Colorectal cancer patients and tumor models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:51.564112+00:00"}
{"study_id": 15006, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the impact of targeting glutaminolysis (via GLS1 ablation) on anti-tumor T cell immunity and exhaustion, comparing it to targeting aerobic glycolysis (via LDHA ablation).", "results_summary": "T cells lacking GLS1 compensated for impaired glutaminolysis by engaging alternative pathways (e.g., upregulating asparagine synthetase), maintaining responsiveness to tumors, chronic infection, and immune checkpoint blockade. Targeting GLS1-dependent glutaminolysis, but not aerobic glycolysis, may be a viable strategy for cancer treatment, especially with immunotherapy.", "population_specificity": "Tumor-responsive T cells and chronic infection models (not human subjects).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:52.260910+00:00"}
{"study_id": 15005, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether polymorphisms in the GLUL gene (related to glutamine synthetase) are associated with hyperammonemia risk during valproic acid (VPA) therapy in epilepsy patients.", "results_summary": "The study found that specific GLUL polymorphisms (rs2296521-A, rs10911021-C, rs12136955-A) and hypertension increased hyperammonemia risk during VPA therapy, while carbamazepine co-therapy may offer protection.", "population_specificity": "180 Egyptian epilepsy patients receiving VPA-based therapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Carbamazepine co-therapy may reduce hyperammonemia risk during VPA treatment.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:52.951806+00:00"}
{"study_id": 15008, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether targeting the YAP1-mediated glutamine metabolic pathway could enhance the efficacy of DFMO in treating metastatic and recurrent osteosarcoma.", "results_summary": "The study found that modulating the YAP1-regulated glutamine metabolic pathway improved the response to DFMO, reducing intracellular ROS levels and countering DFMO resistance. Combining DFMO with YAP1 inhibitor CIL56 or glutaminase inhibitor CB-839 amplified therapeutic efficacy in vitro and in vivo.", "population_specificity": "Patients with metastatic and recurrent osteosarcoma (studied via PDX and CDX models and cell lines).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:53.382885+00:00"}
{"study_id": 15009, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to categorize hepatocellular carcinoma (HCC) patients based on glutamine metabolism-related genes and identify subtypes with different clinical traits, biological behavior, and immune status, as well as predict immunotherapy response.", "results_summary": "The study identified two HCC subtypes (C1 and C2) based on glutamine metabolism-related genes, with C1 associated with lower survival probability, advanced tumor stages, and immunosuppressive characteristics. The pivotal gene SLC1A5 was found to correlate with immunosuppressive status and macrophage infiltration, and low SLC1A5 expression predicted better responsiveness to anti-PD1 therapy.", "population_specificity": "Hepatocellular carcinoma (HCC) patients", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:54.357205+00:00"}
{"study_id": 189348, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the potential role of glutamine in preventing acute kidney injury associated with cardiac surgery, based on experimental and clinical studies.", "results_summary": "Clinical trials showed encouraging results for glutamine supplementation in cardiac surgery, but studies were heterogeneous in design, dosage, and outcomes. Lower glutamine levels post-cardiopulmonary bypass suggest a possible protective role.", "population_specificity": "Patients undergoing cardiac surgery.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:55.479789+00:00"}
{"study_id": 189350, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether glutamine supplementation reduces the incidence of radiodermatitis in cancer patients undergoing radiation therapy.", "results_summary": "The meta-analysis found that glutamine supplementation significantly reduced the incidence of radiodermatitis compared to placebo, with a dose of 20-30 g/day potentially lowering moderate to severe dermatitis.", "population_specificity": "Cancer patients receiving radiation therapy.", "effective_dosage": "20-30 g/day.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:55.931437+00:00"}
{"study_id": 189352, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of glutamine supplementation on hospital stay, mortality, infection, and wound healing in burn patients.", "results_summary": "Glutamine supplementation shortened hospital stays, improved wound healing rates and times, and reduced wound infections, but did not affect non-wound infections, in-hospital mortality, or ICU stay length. The authors do not recommend routine use due to limitations in the available data.", "population_specificity": "Patients with burns (total of 2170 participants across 22 trials).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:58.945330+00:00"}
{"study_id": 189354, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were attempting to determine the effects of a standardized nutritional supplement containing bacterial strains on patients with ulcerative colitis.", "results_summary": "The abstract does not provide specific results regarding Glutamine's effects.", "population_specificity": "Patients with ulcerative colitis (UC).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:59:59.430208+00:00"}
{"study_id": 189353, "supplement_id": 1159, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to determine whether three-week L-glutamine supplementation could improve mucosal immunity, hormonal status, and reduce upper respiratory tract infection (URTI) rates in combat-sport athletes after intensive training.", "results_summary": "L-glutamine supplementation significantly increased salivary IgA and NO levels, reduced URTI incidence, improved hormonal balance (higher T/C ratio), and enhanced subjective well-being compared to the placebo group.", "population_specificity": "Combat-sport athletes from the National Taiwan University of Sport (n=21).", "effective_dosage": "0.3 g/kg body weight daily in powder form.", "study_duration": "3 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:00.268231+00:00"}
{"study_id": 189357, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of enteral glutamine supplementation on clinical outcomes in critically ill patients through an updated meta-analysis of RCTs.", "results_summary": "Enteral glutamine supplementation showed no significant effects on hospital mortality, ICU length of stay, or infectious complications but was associated with a reduction in hospital length of stay. The study concluded that enteral glutamine is unlikely to improve clinical outcomes in critically ill patients except for reducing hospital stay duration.", "population_specificity": "Adult critically ill patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:01.176484+00:00"}
{"study_id": 189356, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to assess the impact of different growth media supplements, including glutamine, on the expansion and characteristics of mesenchymal stromal cells (MSCs).", "results_summary": "The study found that local manufacturing processes significantly influenced MSC expansion, while growth media, including glutamine, affected gene expression and cell function. However, no specific results regarding glutamine's isolated effects were highlighted.", "population_specificity": "Bone marrow-derived mesenchymal stromal cells (MSCs) cultured in vitro.", "effective_dosage": "Not specified", "study_duration": "Cells were taken through two passages; exact duration not specified.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:01.338127+00:00"}
{"study_id": 189358, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of a glutamine-enriched oligomeric diet (GEOD) compared to a standard polymeric diet (SPD) in reducing oncology treatment-related diarrhea and gastrointestinal toxicity in rectal cancer patients.", "results_summary": "The GEOD arm showed improved stool consistency and a greater reduction in stool frequency compared to the SPD arm, indicating a protective effect against gastrointestinal toxicity associated with chemotherapy and radiotherapy.", "population_specificity": "Patients with rectal cancer undergoing neoadjuvant chemotherapy and radiotherapy who were at risk of malnutrition.", "effective_dosage": "400 ml of GEOD or SPD daily.", "study_duration": "From the start of radiotherapy to 30 days after its completion.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:03.192461+00:00"}
{"study_id": 189359, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to determine whether L-glutamine influences survival in patients undergoing chemoradiotherapy for head and neck cancer.", "results_summary": "The study found that L-glutamine reduced the severity of mucositis caused by chemoradiotherapy, but its impact on survival and anti-tumor effects remains controversial.", "population_specificity": "Patients with head and neck cancer undergoing chemoradiotherapy (n=40).", "effective_dosage": "Not specified in the abstract.", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:03.455025+00:00"}
{"study_id": 189362, "supplement_id": 1159, "safety_score": "80", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the radioprotective effects and safety of glutamine as an oral supplement for managing radiation dermatitis.", "results_summary": "The study found that glutamine showed potential radioprotective effects and was well tolerated, though no significant benefits were observed for severe grades of radiation dermatitis. More RCTs with larger samples are needed to confirm efficacy and safety.", "population_specificity": "Patients undergoing radiation therapy (specific condition: radiation dermatitis).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:07.172716+00:00"}
{"study_id": 189363, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of glutamine supplementation on time to discharge, mortality, and bacteremias in severe burn patients.", "results_summary": "The largest randomized controlled trial on glutamine supplementation in burns disproved its anticipated positive effects on time to discharge, mortality, and bacteremias. Evidence of benefits on hard outcomes remains weak due to study design limitations.", "population_specificity": "Severe burn injury patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:07.320682+00:00"}
{"study_id": 189364, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether glutamine supplementation protects cardiac cells during myocardial ischemia in low ejection fraction patients undergoing elective on-pump CABG.", "results_summary": "Glutamine showed a significant negative correlation between CPB duration and cardiac index at 6 hours post-CPB, suggesting myocardial protection. The control group exhibited a positive correlation between AoX duration and plasma troponin I, indicating potential cardiac stress without glutamine.", "population_specificity": "Low ejection fraction patients undergoing elective on-pump CABG.", "effective_dosage": "0.5 g/kg/24 hours.", "study_duration": "24 hours (administered perioperatively).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:09.450938+00:00"}
{"study_id": 189369, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether supplementing sows' gestation diets with glutamine improves placenta growth and functionality, thereby reducing intrauterine growth restriction (IUGR) incidence in piglets.", "results_summary": "Glutamine supplementation improved placenta growth and functionality, reducing IUGR incidence in piglets. However, long-term consequences of IUGR, such as persistent organ deficits and metabolic changes, were not reversed by dietary interventions.", "population_specificity": "Highly prolific sows and their piglets (used as a model for IUGR in infants).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:11.364105+00:00"}
{"study_id": 189370, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to explore whether glutamine supplementation could mitigate the pathophysiological processes of exertional heat stroke (EHS).", "results_summary": "The abstract suggests that glutamine supplementation may dampen the pathophysiological features of EHS, indicating potential protective effects against injury severity. However, further research on human outcomes is required to confirm these findings.", "population_specificity": "Athletes, military personnel, and occupational laborers exposed to strenuous activity in hot/humid conditions or wearing protective equipment.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:11.576894+00:00"}
{"study_id": 189368, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effectiveness of non-pharmacological self-management interventions, including physical exercise, on reducing the severity of chemotherapy-induced peripheral neuropathy (CIPN) in advanced cancer patients.", "results_summary": "The study found that physical exercise showed the greatest confidence in reducing CIPN severity, with a significant standardized mean difference (SMD: -0.89, 95% CI: -1.37 to -0.41). However, the included studies had a high or unclear risk of bias, limiting the certainty of the evidence.", "population_specificity": "People with advanced cancer experiencing chemotherapy-induced peripheral neuropathy (CIPN).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:11.855188+00:00"}
{"study_id": 189367, "supplement_id": 1159, "safety_score": "85", "efficacy_score": 30, "quality_score": 90, "study_goal": "The researchers aimed to determine whether supplemental glutamine reduces the time to discharge alive from the hospital in patients with severe burns.", "results_summary": "The study found no significant difference in time to discharge alive between the glutamine and placebo groups, with median discharge times of 40 and 38 days, respectively. Mortality at 6 months and serious adverse events were also similar between groups.", "population_specificity": "Patients with deep second- or third-degree burns affecting \u226510% to \u226520% of total body-surface area, depending on age.", "effective_dosage": "0.5 g per kilogram of body weight per day, delivered enterally every 4 hours or three to four times daily by mouth.", "study_duration": "Until 7 days after the last skin grafting procedure, discharge from the acute care unit, or 3 months after admission, whichever came first.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:12.185850+00:00"}
{"study_id": 189371, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review advances in therapeutic options for sickle cell disease (SCD), including the role of L-glutamine as an alternative or supplement to hydroxyurea.", "results_summary": "The abstract mentions that L-glutamine, along with crizanlizumab and voxelotor, provides an alternative or supplement to hydroxyurea for disease-modifying therapy in SCD, but specific efficacy data for glutamine are not detailed.", "population_specificity": "Individuals with sickle cell disease (SCD).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:15.359793+00:00"}
{"study_id": 189372, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether oral cystine and glutamine supplementation could reduce markers of gastrointestinal permeability and damage induced by strenuous exercise.", "results_summary": "The study found that cystine and glutamine supplementation significantly lowered plasma L:M ratio and changes in plasma I-FABP, indicating reduced gastrointestinal permeability and damage compared to placebo after 1 hour of strenuous running.", "population_specificity": "Sixteen active men aged 22.7 \u00b1 2.6 years.", "effective_dosage": "Three times a day for 5 days (specific amounts not provided).", "study_duration": "5 days of supplementation followed by a 2-week washout period.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:16.282702+00:00"}
{"study_id": 189373, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect of glutamine supplementation on atherosclerosis markers after exhaustive exercise in young healthy males.", "results_summary": "Glutamine supplementation significantly reduced serum levels of leptin, cholesterol, oxidized low-density lipoprotein, and the ratio of oxidized LDL to HDL after exhaustive exercise, while also showing a non-significant reduction in interleukin-6. It elevated serum adiponectin levels, suggesting potential benefits in reducing atherosclerosis risk.", "population_specificity": "30 healthy young males (15 intervention, 15 control).", "effective_dosage": "0.3 g of glutamine per kilogram of body weight per day, mixed with 25 g of sugar in 250 mL of water.", "study_duration": "14 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:18.841413+00:00"}
{"study_id": 189376, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 60, "study_goal": "The researchers aimed to explore the metabolic profile shared between high-risk groups for severe COVID-19, including low levels of glutamine.", "results_summary": "The study identified low glutamine levels as part of a common metabolic profile in high-risk groups for severe COVID-19, alongside high PAI-1 and STAT3 levels. No direct effects or interventions involving glutamine were reported.", "population_specificity": "High-risk groups for severe COVID-19 (old age, hypertension, cardiovascular diseases, diabetes, obesity).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:19.812416+00:00"}
{"study_id": 189375, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to assess whether glutamine supplementation reduces inflammatory factors, oxidative stress, and improves appetite in COVID-19 patients with respiratory infections.", "results_summary": "Glutamine supplementation significantly reduced serum levels of IL-1\u03b2, TNF-\u03b1, and hs-CRP while significantly increasing appetite compared to the control group.", "population_specificity": "COVID-19 patients with respiratory infections (222 in the glutamine group, 230 in the control group, average age ~51 years).", "effective_dosage": "10 g of glutamine supplement three times per day.", "study_duration": "5 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:20.623672+00:00"}
{"study_id": 189378, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the efficacy of glutamine in preventing and alleviating radiation-induced oral mucositis in head and neck cancer patients.", "results_summary": "Glutamine significantly reduced the severity of radiation-induced oral mucositis, decreased the incidence of severe cases, and lowered rates of opioid use, nasogastric tube feeding, and therapy interruptions, though it did not substantially affect the overall incidence or onset of mucositis.", "population_specificity": "Patients with head and neck cancer undergoing radiation therapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:20.685890+00:00"}
{"study_id": 189377, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the antiproliferative effects of L-glutamine supplementation or deprivation in human hepatocellular carcinoma (HCC) cell lines and its interaction with vorinostat.", "results_summary": "L-glutamine supplementation (4-128 mM) showed dose-dependent antiproliferative effects in HepG2 and Huh7 cells. Glutamine deprivation also suppressed HepG2 cell proliferation, and its combination with vorinostat enhanced sensitivity to the drug.", "population_specificity": "Human hepatocellular carcinoma (HCC) cell lines (HepG2 and Huh7).", "effective_dosage": "4-128 mM L-glutamine.", "study_duration": "Not specified.", "interactions": "Enhanced sensitivity to vorinostat when combined with glutamine concentration changes.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:21.693144+00:00"}
{"study_id": 189380, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect of glutamine supplementation on inflammatory markers in critically ill patients receiving enteral or parenteral feeding.", "results_summary": "The study found that glutamine supplementation significantly reduced CRP levels but had no significant effect on IL-6 or TNF-\u03b1 levels in critically ill patients.", "population_specificity": "Critically ill patients in intensive care units receiving enteral or parenteral feeding.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:23.843665+00:00"}
{"study_id": 189382, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to investigate the effects of probiotic supplementation on cytokine production by monocytes and upper respiratory tract infections after strenuous exercise, not Glutamine.", "results_summary": "The abstract does not mention Glutamine or its effects; it focuses on probiotics.", "population_specificity": "Fourteen healthy male marathon runners.", "effective_dosage": "Not mentioned (study used probiotics, not Glutamine).", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:27.044503+00:00"}
{"study_id": 189361, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to systematically review the effect of glutamine supplementation on mortality and clinical outcomes in severe adult burn patients.", "results_summary": "Glutamine supplementation showed no significant effect on overall mortality, infectious complications, or other secondary outcomes. Subgroup analyses revealed a significant effect in single-center RCTs, but trial sequential analysis indicated these results were likely type 1 errors.", "population_specificity": "Severe adult burn patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:27.150394+00:00"}
{"study_id": 189381, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to review the literature on the influence of glutamine, among other nutrients, for the prevention and/or treatment of oral mucositis in patients with head and neck cancer.", "results_summary": "Glutamine, along with vitamin E and zinc, showed positive effects on the manifestation and severity of oral mucositis due to its antioxidant and immunomodulatory properties, though some studies suggest antioxidants may reduce the effectiveness of antineoplastic therapy.", "population_specificity": "Patients with head and neck cancer undergoing anticancer therapies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:27.496554+00:00"}
{"study_id": 189383, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to assess the effect of glutamine supplementation on cardio-metabolic risk factors and inflammatory markers through a systematic review and meta-analysis of controlled trials.", "results_summary": "Glutamine supplementation significantly decreased serum levels of fasting plasma glucose (FPG) and C-reactive protein (CRP), but had no significant effect on other cardio-metabolic risk factors.", "population_specificity": "Not specified (included randomized clinical trials without population restrictions).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:28.380027+00:00"}
{"study_id": 189384, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to determine the effects of oral L-glutamine supplementation, with or without physical exercise, on glycemia, oxidative stress, and knee muscle strength/power in elderly women.", "results_summary": "The abstract does not provide specific results, but the study investigated Glutamine's impact on glycemia, oxidative stress, and muscle strength/power in elderly women, potentially in combination with physical exercise.", "population_specificity": "Elderly women who were physically active.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:28.518638+00:00"}
{"study_id": 189385, "supplement_id": 1159, "safety_score": "85", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to systematically evaluate the effects of glutamine supplementation on inflammatory bowel disease (IBD) based on evidence from randomized clinical trials.", "results_summary": "The review found that glutamine supplementation had no significant effect on disease course, anthropometric measurements, intestinal permeability, morphology, disease activity, or biochemical parameters in IBD patients. Only minor effects on inflammation, oxidative stress, and intestinal permeability were reported in a few studies.", "population_specificity": "Patients with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis.", "effective_dosage": "Oral (21-30g or 0.5g/kg body weight), enteral (7.87g-8.3g/100g of enteral formula), and parenteral (0.3g/kg body weight).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:31.826362+00:00"}
{"study_id": 189386, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 70, "study_goal": "The researchers aimed to review prophylactic treatments, including glutamine, that may increase the safety and efficacy of acetaminophen for early closure of the ductus arteriosus in immature infants.", "results_summary": "The abstract mentions glutamine as one of the prophylactic treatments that may enhance the safety and efficacy of acetaminophen, but no specific results regarding glutamine's effects are provided.", "population_specificity": "Immature infants with patent ductus arteriosus.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:32.077522+00:00"}
{"study_id": 189387, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the benefits of glutamine supplementation on oral mucositis (OM) and OM-related adverse reactions in cancer patients undergoing chemotherapy and/or radiotherapy.", "results_summary": "Glutamine did not reduce the incidence of OM but significantly reduced its severity and the incidence of severe OM. It also lowered the need for opioid analgesics, feeding tubes, hospitalization, and treatment interruptions caused by OM.", "population_specificity": "Cancer patients receiving chemotherapy and/or radiotherapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:35.107198+00:00"}
{"study_id": 189389, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether glutamine supplementation, combined with maltodextrin, could alter perceived exertion and physiological markers during high-intensity running under hypoxic conditions.", "results_summary": "The study compared glutamine supplementation with maltodextrin to placebo and maltodextrin alone under hypoxia, but the abstract does not specify the outcomes for glutamine.", "population_specificity": "Nine volunteers (specific demographics not provided).", "effective_dosage": "20 g/day of glutamine.", "study_duration": "Six days of glutamine supplementation.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:35.808159+00:00"}
{"study_id": 189391, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to elucidate the relationship between plasma glutamine levels and endogenous glutamine production in ICU patients, particularly to determine if low glutamine levels are linked to reduced production.", "results_summary": "The study found a statistically significant correlation between endogenous glutamine production and plasma glutamine concentrations in ICU patients, suggesting that low plasma glutamine may indicate insufficient production, warranting supplementation.", "population_specificity": "Circulatory stabilized ICU patients (n=19).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:36.280167+00:00"}
{"study_id": 189388, "supplement_id": 1159, "safety_score": "90", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether glutamine reduces the severity of acute radiation-induced esophagitis (ARIE) in patients with advanced thoracic malignancies receiving radiotherapy.", "results_summary": "Glutamine did not significantly reduce the incidence or severity of ARIE compared to placebo, though it showed a non-significant trend toward shorter duration of esophagitis and less weight loss. No grade 3 or higher adverse events related to glutamine were reported.", "population_specificity": "Patients with advanced thoracic malignancies receiving concurrent chemotherapy/radiotherapy or radiotherapy alone, with esophageal radiation doses \u226545 Gy.", "effective_dosage": "4 g twice daily", "study_duration": "Duration of radiotherapy (specific length not stated, but interim analysis at 6 weeks)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:36.334204+00:00"}
{"study_id": 189392, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of glutamine in white adipose tissue inflammation and its potential therapeutic effects on insulin resistance and type 2 diabetes.", "results_summary": "The study found that reduced glutamine levels in adipocytes promote pro-inflammatory gene transcription via increased UDP-GlcNAc levels and nuclear O-GlcNAcylation. Glutamine supplementation reversed these effects in vitro and in vivo, suggesting a potential therapeutic role in mitigating inflammation and metabolic dysfunction.", "population_specificity": "Human white adipose tissue (WAT) in obese individuals.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:36.479062+00:00"}
{"study_id": 189379, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of a Standard nutritional supplement versus an Enhanced supplement (containing three nutriceuticals, potentially including Glutamine) on functional outcomes in boys with Duchenne muscular dystrophy (DMD).", "results_summary": "The Enhanced supplement showed a modest but inconclusive positive effect on functional outcomes (e.g., 6-minute walk distance), but no significant impact on body composition or quality of life. The small sample size limited the conclusiveness of the findings.", "population_specificity": "Ambulatory boys with Duchenne muscular dystrophy (DMD) in Australia.", "effective_dosage": "Not specified for Glutamine (study focused on combined nutritional supplements).", "study_duration": "50 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:36.557581+00:00"}
{"study_id": 189393, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether immunonutrition (including glutamine) improves clinical outcomes in patients with acute pancreatitis compared to standard nutrition.", "results_summary": "Immunonutrition significantly reduced organ failure, infectious complications, mortality, hospital stay length, and total interventions, while also improving body mass index compared to standard nutrition.", "population_specificity": "Patients with acute pancreatitis", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:40.233034+00:00"}
{"study_id": 189394, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to characterize the gastrointestinal tolerance of acute high-dose oral glutamine supplementation in healthy males.", "results_summary": "The study examined GI tolerance of glutamine at varying doses (0.3, 0.6, and 0.9 g\u00b7kg\u00b7FFM) but did not report specific efficacy outcomes or adverse effects in the abstract.", "population_specificity": "Healthy males (25 \u00b1 5 years, 14.8 \u00b1 4.6% body fat).", "effective_dosage": "0.3 (LOW), 0.6 (MED), or 0.9 (HIGH) g\u00b7kg\u00b7FFM.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:41.642736+00:00"}
{"study_id": 189398, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the role of glutamine, among other amino acids, in supporting conceptus growth, development, and pregnancy outcomes.", "results_summary": "Glutamine, along with arginine and leucine, was found to stimulate conceptus growth and development, enhance interactions between the maternal uterus and the conceptus, and positively impact placental and fetal development. Supplementation of certain amino acids, including glutamine, partially rescued fetal growth restriction in cases of gestational protein undernutrition.", "population_specificity": "Conceptus (embryo and extraembryonic membranes) and maternal uterus in early pregnancy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:44.784586+00:00"}
{"study_id": 189397, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine how mutant KRAS-mediated glutaminolysis affects the epigenomes and activities of colorectal cancer (CRC) cells.", "results_summary": "The study found that CRC cells with activated KRAS required glutamine for survival and proliferation, leading to epigenetic alterations and hypermethylation of genes in the WNT signaling pathway. Disruption of this pathway reduced WNT signaling and stem cell features, suggesting glutaminolysis as a potential therapeutic target.", "population_specificity": "Colorectal cancer (CRC) cells with mutant KRAS.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:45.331025+00:00"}
{"study_id": 189402, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to investigate the effect of L-glutamine supplementation on serum HSP27 and HSP70 levels and metabolite levels in patients with atrial fibrillation.", "results_summary": "The abstract does not provide specific results regarding the effects of L-glutamine, only stating that it is an HSP-inducing compound being studied for its potential to mitigate AF onset and progression.", "population_specificity": "Patients with atrial fibrillation.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:45.331560+00:00"}
{"study_id": 189401, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "To determine if oral glutamine prevents oral mucositis and reduces hospital costs in children with ALL undergoing Methotrexate chemotherapy.", "results_summary": "Glutamine significantly reduced oral mucositis incidence (4.2% vs. 62.5%) and hospital stay duration (8 vs. 12 days) compared to placebo, while lowering daily hospital costs (40 USD vs. 48 USD).", "population_specificity": "Children with acute lymphoblastic leukemia (ALL) receiving Methotrexate chemotherapy.", "effective_dosage": "400 mg/kg body weight per day.", "study_duration": "Administered on chemotherapy days and for at least 14 additional days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:45.679749+00:00"}
{"study_id": 189399, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of L-glutamine and other amino acids in modulating vascular function and mitigating cardiovascular disease risk factors.", "results_summary": "L-glutamine, along with other amino acids, was found to preserve vascular homeostasis by regulating cellular processes, exerting anti-inflammatory and antioxidant effects, and reducing cardiovascular risk factors like hypertension and hyperlipidemia. However, some metabolic pathways of these amino acids may yield compounds that promote vascular disease.", "population_specificity": "Not specified (general discussion of vascular disease and amino acid effects, likely based on animal models and clinical observations).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:45.825321+00:00"}
{"study_id": 189403, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether L-glutamine supplementation could improve inflammatory status and redox balance in elderly individuals practicing combined-exercise training.", "results_summary": "The study compared salivary levels of nitric oxide (NO) in elderly subjects before and after 30 days of L-glutamine or placebo supplementation, but the abstract does not provide conclusive results on Glutamine's efficacy.", "population_specificity": "Elderly subjects (nonpractitioners and practitioners of combined-exercise training, aged ~71-73 years).", "effective_dosage": "Not specified in the abstract.", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:48.522502+00:00"}
{"study_id": 189404, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to assess the effects of various interventions, including oral glutamine, on taste recovery in patients with taste disorders.", "results_summary": "The study included oral glutamine as one of several interventions but did not provide specific efficacy results for glutamine alone. The overall quality of evidence for interventions ranged from poor to high.", "population_specificity": "Patients with taste disorders, including those induced by drugs or disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:49.147595+00:00"}
{"study_id": 189405, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether parenteral glutamine supplementation has a significant effect on mortality, infection rates, and hospital stay duration in critically ill surgical patients.", "results_summary": "Parenteral glutamine supplementation was associated with a non-significant 24% reduction in mortality, a significant reduction in infections (RR = 0.60), and a 4.09-day shorter hospital stay.", "population_specificity": "Critically ill surgical patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:52.662543+00:00"}
{"study_id": 189406, "supplement_id": 1159, "safety_score": "Not Assessed", "efficacy_score": 22, "quality_score": 65, "study_goal": "The researchers aimed to assess adherence to nutrition guidelines, including glutamine supplementation, in burn ICU patients.", "results_summary": "Glutamine supplementation occurred in 22.4% of patient-days, with significant variation across sites (0.0%-61.8%). The study did not report specific outcomes related to glutamine's efficacy.", "population_specificity": "Mechanically ventilated burn patients admitted to ICUs for at least 72 hours.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:00:52.942256+00:00"}
